千葉大学病院

冠動脈疾患治療部

2024年

39. Miura K, Takaoka H, Ota M, Irie R, Ota J, Noguchi Y, Nishikawa Y, Yoshida K, Suzuki K, Aoki S, Yashima S, Kinoshita M, Suzuki-Eguchi N, Sasaki H, Kobayashi Y. Utility of Computed Tomography for the Initial Detection and Follow-up of Silent Coincidence of IgG4-Related Pericarditis, Periaortitis, and Coronary Arteritis. Circ Rep. 2024 Jan 16;6(2):28-29.
    
    
38. Kono Y, Miura K, Kasai H, Ito S, Asahina M, Tanabe M, Nomura Y, Nakaguchi T. Breath Measurement Method for Synchronized Reproduction of Biological Tones in an Augmented Reality Auscultation Training System. Sensors. 2024 Mar 1;24(5):1626.
    
    
37. Vogelhuber J, Tanaka T, Kavsur R, Goto T, Öztürk C, Silaschi M, Nickenig G, Zimmer S, Weber M, Sugiura A. Outcome of right ventricular dysfunction in patients undergoing transcatheter tricuspid edge-to-edge repair. Circ Cardiovasc Interv. 2024 Apr 17:e013156.
    
    
36. Sugiura A, Yamamoto M, Saji M, Asami M, Enta Y, Nakashima M, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Yagaguchi J, Nakajima Y, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Adachi Y, Otsuka T, Kubo S, Nickenig G, Hyashida K, the OCEAN-Mitral Investigators. Cardiac damage in degenerative mitral regurgitation treated with transcatheter mitral edge-to-edge repair. Circ Cardiovasc Interv. 2024 Apr 17:e013794.
    
    
35. Taube L, Sugiura A, Hartmann A, Schaefer C, Hamiko M, Zimmer S, Nickenig G, Schahab N. Carotid artery stenosis as a predictor for stroke following transcatheter aortic valve implantation. Angiology. 2024 Mar 13:33197241239687.
    
    
34. Sugiura A, Tanaka T, Kavsur R, Öztürk C, Silaschi M, Goto T, Weber M, Zimmer S, Nickenig G, Vogelhuber J. Refining accuracy of RV-PA coupling in patients undergoing transcatheter tricuspid valve treatment. Clin Res Cardiol. 2024 Jan;113(1):177-186.
    
    
33. Tanaka T, Sugiura A, Kavsur R, Öztürk C, Wilde N, Zimmer S, Nickenig G, Weber M, Vogelhuber J. Changes in right ventricular function and clinical outcomes following tricuspid transcatheter edge-to-edge repair. Eur J Heart Fail. 2024 Mar 7.
    
    
32. Tanaka T, Sugiura A, Vogelhuber J, Öztürk C, Böhm L, Wilde N, Zimmer S, Nickenig G, Weber M. Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation. EuroIntervention. 2024 Feb 19;20(4):e250-e260.
    
    
31. Tanaka T, Sugiura A, Schulz M, Wilde N, Vogelhuber J, Sudo M, Zimmer S, Nickenig G, Weber M. Cardiac computed tomography-based assessment of mitral annular calcification in patients undergoing mitral transcatheter edge-to-edge repair. J Cardiovasc Comput Tomogr. 2024 Jan-Feb;18(1):26-32.
    
    
30. Tanaka T, Balata M, Sugiura A, Kavsur R, Vogelhuber J, Öztürk C, Zimmer S, Nickenig G, Weber M. Chronic Obstructive Pulmonary Disease and Clinical Outcomes After Transcatheter Tricuspid Valve Repair. JACC Cardiovasc Interv. 2024 Jan 8;17(1):106-107.
    
    
29. Vogelhuber J, Tanaka T, Sudo M, Sugiura A, Öztürk C, Kavsur R, Donner A, Nickenig G, Zimmer S, Weber M, Wilde N. Impact of body mass index in patients with tricuspid regurgitation after transcatheter edge-to-edge repair. Clin Res Cardiol. 2024 Jan;113(1):156-167.
    
    
28. Nickenig G. Sugiura A. Transcatheter Myotomy for LVOT Challenges: SESAME Street 2.0. J Am Coll Cardiol 2024 Apr 9;83(14):1273-1275.
    
    
27. Kim M, Kang DY, Ahn JM, Kim JB, Yeung AC, Nishi T, Fearon WF, Cantey EP, Flaherty JD, Davidson CJ, Malaisrie SC, Kim HJ, Lee J, Park J, Kim H, Cho S, Choi Y, Park SJ, Park DW. Sex-Specific Disparities in Clinical Outcomes After Transcatheter Aortic Valve Replacement Among Different Racial Populations. JACC Asia. 2024 Feb 13;4(4):292-302.
    
    
26. Nishi T, Kume T, Ueno M, Kobayashi Y, Uemura S. Resolution of spontaneous coronary artery dissection involving the left main coronary artery. Cardiovasc Interv Ther. 2024 Mar 23.
    
    
25. Kume T, Nishi T, Murasato Y, Koto S, Sasahira Y, Okamoto H, Yamada R, Koyama T, Tamada T, Imai K, Neishi Y, Uemura S. Impact of stent strut link location in proximal balloon edge dilation technique for bifurcation percutaneous coronary intervention. Cardiovasc Interv Ther. 2024 Apr;39(2):137-144.
    
    
24. Nishi T. Left ventricular thrombus and stroke: Are coronary interventions a safe path? Int J Cardiol. 2024 Jan 15;395:131571.
    
    
23. Saito Y, Inohara T, Kohsaka S, Muramatsu T, Ishii H, Yamaji K, Amano T, Kobayashi Y, Kozuma K, on behalf of the J-PCI Registry Investigators. Door-to-Balloon Time and Mortality in ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock: A Nationwide Registry. JACC Asia. 2024. In press.
    
    
22. Saito Y, Nishi T, Kobayashi Y. Letter Regarding Article, “ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial”. Circulation. 2024. In press.
    
    
21. Saito Y, Yaginuma H, Asada K, Goto H, Sato T, Kitahara H, Kobayashi Y. Prognostic Impact of Previous Atherosclerotic Cardiovascular Disease on Short- and Long-Term Outcomes in Acute Myocardial Infarction. Am J Cardiol. 2024:217:18-24.
    
    
20. Kinoshita Y, Saito Y, Kikuta Y, Sato K, Taniguchi M, Goto K, Takebayashi H, Haruta S, Kobayashi Y. Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing. Ther Adv Cardiovasc Dis. 2024:18:17539447241233168.
    
    
19. Saito Y, Inohara T, Kohsaka S, Wada H, Kumamaru H, Yamaji K, Ishii H, Amano T, Miyata H, Kobayashi Y, Kozuma K, for the J-PCI Registry Investigators. Benchmarking System Monitoring on Quality Improvement in Percutaneous Coronary Intervention: A Nationwide Registry in Japan. JACC Asia. 2024.
    
    
18. Saito Y, Kanagami T, Kobayashi Y. Reply to: The role of CT in acute type A aortic intramural hematoma. Int J Cardiol. 2024;397:131648.
    
    
17. Saito Y, Tateishi K, Kanda M, Shiko Y, Kawasaki Y, Kobayashi Y, Inoue T. Volume-outcome relationships for extracorporeal membrane oxygenation in acute myocardial infarction. Cardiovasc Interv Ther. 2024 Apr;39(2):156-163.
    
    
16. Saito Y, Tanaka A, Imai T, Miura S, Ajioka M, Kodama K, Kobayashi Y, Node K, on behalf of the PROTECT investigators. Factors associated with the uric acid-lowering effects of sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes: insights from the randomized PROTECT trial. Diabetes Obes Metab. 2024;26:1110-3.
    
    
15. Saito Y, Tanaka A, Imai T, Nakamura I, Kanda J, Matsuhisa M, Uehara H, Kario K, Kobayashi Y, Node K, on behalf of the PROTECT investigators. Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: Insights from the randomized PROTECT trial. Hypertens Res. 2024;47:168-76.
    
    
14. Tateishi K, Hmoud H, De Gregorio I, Hastings R, De Gregorio J. The impact of gender on outcomes of transcatheter aortic valve implantation between self-expanding valve and balloon-expandable valve. Cardiovasc Revasc Med. 2024 Jan 9:S1553-8389(24)00003-4.
    
    
13. Okuya Y, Saito Y, Kitahara H, Kobayashi Y. Relation of Vasoreactivity in the Left and Right Coronary Arteries During Acetylcholine Spasm Provocation Testing. Am J Cardiol. 2024;219:71-76
    
    
12. Yamazaki T, Saito Y, Yamashita D, Kitahara H, Kobayashi Y. Relation of Thrombolysis in Myocardial Infarction Frame Count to Invasively Measured Coronary Physiologic Indexes. Am J Cardiol. 2024 Jan 15;211:282-286.
    
    
11. Abe K, Kitahara H, Suzuki S, Hiraga T, Yamazaki T, Ohno Y, Harada J, Fukushima K, Asano T, Ishio N, Uchiyama R, Miyahara H, Okino S, Sano M, Kuriyama N, Yamamoto M, Sakamoto N, Kanda J, Kobayashi Y. Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention. Int J Cardiology. 2024 Jun 15:405:131989.
    
    
10. Hiroaki Yaginuma, Yuichi Saito, Hiroki Goto, Kazunari Asada, Yuki Shiko, Takanori Sato, Osamu Hashimoto, Hideki Kitahara, Yoshio Kobayashi. Impact of Cancer, Inflammation, and No Standard Risk Factors in Patients With Myocardial Infarction. JACC Aisa. 2024. In press.
    
    
9. Yamamoto K, Saito Y, Hashimoto O, Nakayama T, Okino S, Sakai Y, Nakamura Y, Fukuzawa S, Himi T, Kobayashi Y. Biomarkers for Risk Stratification in Patients With Type A Acute Aortic Dissection. Am J Cardiol. 2024 Feb 1;212:103-108.
   
   
8. Ohnaga Y, Takaoka H, Kato K, Daimon M, Ota J, RT, Noguchi Y, Nishikawa Y, Matsumoto M, Yoshida K, Suzuki K, Aoki S, Yashima S, Kinoshita M, Suzuki-Eguchi N, Sasaki H, Kobayashi Y. IgG4-Related Coronary Arteritis With Acetylcholine-Induced Coronary Vasospasm. Circ Rep. 2024 Mar 19;6(4):149-150.
   
   
7. Kitahara H, Kumamaru H, Kohsaka S, Yamashita D, Kanda T, Matsuura K, Shimamura K, Matsumiya G, Kobayashi Y. Clinical Outcomes of Urgent or Emergency Transcatheter Aortic Valve Implantation - Insights From the Nationwide Registry of Japan Transcatheter Valve Therapies. Circ J. 2024 Mar 25;88(4):439-447.
   
   
6. Saito Y, Kobayashi Y. Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023). Cardiovasc Interv Ther. 2024 Jan;39(1):15-17.
   
   
5. Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Kozuma K, Honye J. CVIT 2023 clinical expert consensus document on intravascular ultrasound. Cardiovasc Interv Ther. 2024 Jan;39(1):1-14.
   
   
4. Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Diagnostic ability of Japanese version of high bleeding risk criteria for ischemic outcomes in patients with acute myocardial infarction. Heart Vessels. 2024 Jan;39(1):1-9.
   
   
3. Yamashita D, Saito Y, Sato T, Matsumoto T, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Combinations of PARIS and CREDO-Kyoto Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients With Acute Myocardial Infarction. Intern Med. 2024 Feb 15;63(4):475-480.
   
   
2. Okuya Y, Saito Y, Kitahara H, Kobayashi Y. Omitting 50 μg of intracoronary acetylcholine injection in the left coronary artery during spasm provocation test. J Cardiol. 2024 Jan;83(1):25-29.
   
   
1. Hashimoto O, Saito Y, Sasaki H, Yumoto K, Oshima S, Tobaru T, Kanda J, Sakai Y, Yasuda S, A Collaboration with the Angina Pectoris-Myocardial Infarction Multicenter Investigators. Treatment Strategies and In-Hospital Mortality in Patients with Type A Acute Aortic Dissection and Coronary Artery Involvement. J Thorac Cardiovasc Surg. 2024 Feb;167(2):596-601.e3.

2023年

63. Saito Y, Ichihara S, Hashimoto O, Nakayama T, Sasaki H, Yumoto K, Oshima S, Tobaru T, Kushida S, Kanda J, Sakai Y, Okino S, Fukuzawa S, Abiko A, Itoh T, Nakamura Y, Nakashima T, Yasuda S, Goto K, Takebayashi H, Oshitomi T, Sakamoto T, Kojima S, Otsuka Y, Himi T, Inagaki Y, Yamaguchi J, Hagiya K, Nanasato M, Kobayashi Y. Timing of Recognition of Type A Acute Aortic Dissection in Acute Myocardial Infarction. Am J Cardiol. 2023:207:428-30.
    
    
62. Tateishi K, Hmoud H, De Gregorio L, De Gregorio I, Asselin CY, De Gregorio J. Impact of Cardiac and Cerebrovascular Complications During Hospitalization on Long-Term Prognosis in Patients With COVID-19. Am J Cardiol. 2023 Dec 15;209:114-119.
    
    
61. Yamazaki T, Saito Y, Kitahara H, Kobayashi Y. Thrombolysis in Myocardial Infarction Frame Count for Coronary Blood Flow Evaluation during interventional Diagnostic Procedures. Medicina (Kaunas). 2023 Dec 15;59(12):2185.
    
    
60. Kanagami T, Saito Y, Hashimoto O, Nakayama T, Okino S, Sakai Y, Nakamura Y, Fukuzawa S, Himi T, Kobayashi Y. Clinical characteristics and outcomes in patients with acute type A aortic intramural hematoma. Int J Cardiol. 2023:391:131355.
    
    
59. Nelles D, Amli H, Sugiura A, Vij V, Beiert T, Nickenig G, Kütting D, Schrickel JW, Sedaghat A. The CT derived angle between the transseptal puncture site and the left atrial appendage as a predictor for complex interventional occlusion procedures. Echocardiography 2023 Nov;40(11):1227-1236.
    
    
58. Matsuura K, Kumamaru H, Kohsaka S, Kanda T, Yamashita D, Kitahara H, Shimamura K, Kobayashi Y, Matsumiya G. Impact of concomitant mitral regurgitation during transcatheter aortic valve replacement on 1-year survival outcomes. J Cardiol. 2023 Jul;82(1):16-21.
    
    
57. Tanaka S, Okada K, Kitahara H, Luikart H, Yock PG, Yeung AC, Schnittger I, Tremmel JA, Fitzgerald PJ, Khush KK, Fearon WF, Honda Y. Impact of myocardial bridging on coronary artery plaque formation and long-term mortality after heart transplantation. Int J Cardiol. 2023 May 15:379:24-32.
    
    
56. Nishiori H, Matsuura K, Yakita Y, Kanda T, Kitahara H, Yamashita D, Kobayashi Y, Matsumiya G. Annular rupture during transcatheter aortic valve replacement in a long-term corticosteroid user: a case report. J Surg Case Rep. 2023 May 30;2023(5):rjad317.
    
    
55. Kitahara H, Yamashita D, Sato T, Suzuki S, Hiraga T, Yamazaki T, Matsumoto T, Kobayashi T, Ohno Y, Harada J, Fukushima K, Asano T, Ishio N, Uchiyama R, Miyahara H, Okino S, Sano M, Kuriyama N, Yamamoto M, Sakamoto N, Kanda J, Kobayashi Y. Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention. J Cardiol. 2023 Sep;82(3):207-214.
    
    
54. Balata M, Gbreel MI, Elrashedy AA, Westenfeld R, Pfister R, Zimmer S, Nickenig G, Becher MU, Sugiura A. Clinical effects of cognitive behavioral therapy in heart failure patients: a meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2023 Aug 7;23(1):280.
    
    
53. Sudo M, Vij V, Wilde N, Tanaka T, Vogelhuber J, Silaschi M, Weber M, Bakhtiary F, Nickenig G, Zimmer S, Sugiura A. Contemporary Treatment and Outcomes of High Surgical Risk Mitral Regurgitation. J Clin Med. 2023 Apr 19;12(8):2978.
    
    
52. Sugiura A et al. Tricuspid valve anatomy according to severity of tricuspid regurgitation: computed tomography analysis. J Cardiovasc Comput Tomogr. 2023 Mar-Apr;17(2):96-104.
    
    
51. Sugiura A et al. Impact of new eGFR equations on CKD prevalence and risk assessment. CRM 2023. Cardiovasc Revasc Med. 2023 Apr;49:42-46.
    
    
50. Nickenig G, Sugiura A. Sex and TTVI: equality in efficacy. JACC Cardiovasc Interv. 2023 Apr 24;16(8):924-926.
    
    
49. Kavsur R, Schaefer C, Stumpf MJ, Weber M, Sugiura A, Becher MU, Zimmer S, Nickenig G, Schahab N. Carotid Stiffness After Transcatheter Aortic Valve Replacement. Angiology 2023 Aug 12:33197231195647.
    
    
48. Wilde N, Silaschi M, Alirezaei H, Vogelhuber J, Sugiura A, Tanaka T, Sudo M, Kavsur R, Cattelaens F, El-Sayed Ahmad A, Doss M, Fehske W, Zimmer S, Nickenig G, Bakhtiary F, Weber M. Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study. EuroIntervention. 2023 Oct 23;19(8):659-661.
    
    
47. Vogelhuber J, Tanaka T, Sugiura A, Galka N, Hupp-Herschel HE, Becher MU, Zimmer S, Nickenig G, Kavsur R, Weber M. Association of TRI-SCORE With Clinical Outcomes After Transcatheter Tricuspid Valve Repair. JACC Cardiovasc Interv. 2023 Jul 10;16(13):1698-1700.
    
    
46. Tanaka T, Sugiura A, Kavsur R, Öztürk C, Vogelhuber J, Wilde N, K√ºtting D, Meyer C, Zimmer S, Grube E, Bakhtiary F, Nickenig G, Weber M. Right ventricular ejection fraction assessed by computed tomography in patients undergoing transcatheter tricuspid valve repair. Eur Heart J Cardiovasc Imaging. 2023 Oct 27;24(11):1501-1508.
    
    
45. Wilde NG, Mauri V, Piayda K, Al-Kassou B, Shamekhi J, Maier O, Tiyerili V, Sugiura A, Weber M, Zimmer S, Zeus T, Kelm M, Adam M, Baldus S, Nickenig G, Veulemans V, Sedaghat A. Left ventricular reverse remodeling after transcatheter aortic valve implantation in patients with low-flow low-gradient aortic stenosis. Hellenic J Cardiol. 2023 Nov-Dec;74:1-7.
    
    
44. Al-Kassou B, Al-Shaikh H, Aksoy A, Shamekhi J, Zietzer A, Sugiura A, Veulemans V, Adam M, Grube E, Bakhtiary F, Zimmer S, Kelm M, Baldus S, Nickenig G, Sedaghat A. Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications. Int J Cardiol Heart Vasc. 2023 Apr 13;46:101205.
    
    
43. Kim H, Kang DY, Ahn JM, Kim JB, Yeung AC, Nishi T, Fearon WF, Cantey EP, Flaherty JD, Davidson CJ, Malaisrie SC, Kim N, Kim M, Lee J, Park J, Choi Y, Park SJ, Park DW. Race-Specific Impact of Conventional Surgical Risk Score on 1-Year Mortality After Transcatheter Aortic Valve Replacement. JACC Asia. 2023 Feb 28;3(3):376-387.
    
    
42. Nishi T, Kume T, Yamada R, Neishi Y, Uemura S. Variation of the Appearance of Intraplaque Hemorrhage on Optical Coherence Tomography and Intravascular Ultrasound. JACC Cardiovasc Interv. 2023 Apr 24;16(8):997-999.
    
    
41. Okamoto H, Kume T, Nishi T, Koto S, Sasahira Y, Yamada R, Koyama T, Tamada T, Imai K, Neishi Y, Uemura S. Efficacy of Optical Coherence Tomography-Guided Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome. Acta Cardiol Sin. 2023 Mar;39(2):266-276.
    
    
40. Nishi T, Kume T, Uemura S. Resuscitated sudden cardiac arrest related to intraplaque haemorrhage and coronary artery spasm. Eur Heart J. 2023 May 14;44(19):1766.
    
    
39. Nishi T, Kume T, Yamada R, Koto S, Sasahira Y, Okamoto H, Tamada T, Koyama T, Imai K, Neishi Y, Ughi GJ, Uemura S. Efficacy of a new generation intracoronary optical coherence tomography imaging system with fast pullback. Catheter Cardiovasc Interv. 2023 Feb;101(3):520-527.
    
    
38. Nishi T, Sasahira Y, Kume T, Koto S, Uemura S. Rapid progression of calcified nodules with increased lipid core burden in the right coronary artery. Cardiovasc Interv Ther. 2023 Apr;38(2):248-250.
    
    
37. De Filippo O, Cammann VL, Pancotti C, Di Vece D, Silverio A, Schweiger V, Niederseer D, Szawan KA, Würdinger M, Koleva I, Dusi V, Bellino M, Vecchione C, Parodi G, Bossone E, Gili S, Neuhaus M, Franke J, Meder B, Jaguszewski M, Noutsias M, Knorr M, Jansen T, Dichtl W, Lewinski DV, Burgdorf C, Kherad B, Tschöpe C, Sarcon A, Shinbane J, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Karakas M, Koenig W, Pott A, Meyer P, Roffi M, Banning A, Wolfrum M, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Napp LC, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Chan C, Bridgman P, Beug D, Delmas C, Lairez O, Gilyarova E, Shilova A, Gilyarov M, El-Battrawy I, Akin I, Poledniková K, Toušek P, Winchester DE, Massoomi M, Galuszka J, Ukena C, Poglajen G, Carrilho-Ferreira P, Hauck C, Paolini C, Bilato C, Kobayashi Y, Kato K, et al. Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model. Eur J Heart Fail. 2023 Dec;25(12):2299-2311.
    
    
36. Kanagami T, Saito Y, Hashimoto O, Nakayama T, Okino S, Sakai Y, Nakamura Y, Fukuzawa S, Himi T, Kobayashi Y. Clinical characteristics and outcomes in patients with acute type A aortic intramural hematoma. Int J Cardiol. 2023 Nov 15;391:131355.
    
    
35. Saito Y, Ichihara S, Hashimoto O, Nakayama T, Sasaki H, Yumoto K, Oshima S, Tobaru T, Kushida S, Kanda J, Sakai Y, Okino S, Fukuzawa S, Abiko A, Itoh T, Nakamura Y, Nakashima T, Yasuda S, Goto K, Takebayashi H, Oshitomi T, Sakamoto T, Kojima S, Otsuka Y, Himi T, Inagaki Y, Yamaguchi J, Hagiya K, Nanasato M, Kobayashi Y. Timing of Recognition of Type A Acute Aortic Dissection in Acute Myocardial Infarction. Am J Cardiol. 2023 Nov 15;207:428-430.
    
    
34. Saito Y, Tateishi K, Toda K, Matsumiya G, Kobayashi Y, for the J-PVAD registry study investigators. Complications and Outcomes of Impella treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction. J Am Heart Assoc. 2023;12:e030819.
    
    
33. Saito Y, Tanaka A, Ishizu T, Yoshida H, Kubota Y, Nanasato M, Matsuhisa M, Ohya Y, Kobayashi Y, Node K, for the PRIZE Study Investigators. Factors associated with carotid intima-media thickness progression in patients with asymptomatic hyperuricemia: Insights from the PRIZE study. Sci Rep. 2023;13:10927.
    
    
32. Ichihara S, Saito Y, Hashimoto O, Sasaki H, Yumoto K, Oshima S, Tobaru T, Kanda J, Sakai Y, Yasuda S. Timing of Myocardial Infarction Diagnosis in Type A Acute Aortic Dissection and Coronary Artery Involvement. JACC Asia. 2023;3:531-3.
    
    
31. Sato T, Saito Y, Kitahara H, Kobayashi Y. Relation of GRACE Risk Score to Coronary Lipid Core Plaques in Patients With Acute Coronary Syndrome. Life (Basel). 2023;13:630.
    
    
30. Thomas A, Gitto M, Shah S, Saito Y, Chieffo A, Stefanini GG, Lansky AJ. Antiplatelet Strategies Following PCI: A Review of Trials Informing Current and Future Therapies. JSCAI. 2023;2:100607.
    
    
29. Saito Y, Inohara T, Kohsaka S, Ando H, Ishii H, Yamaji K, Amano T, Kobayashi Y, Kozuma K, for the J-PCI Registry Investigators. Volume-outcome relationships of percutaneous coronary intervention in patients presenting with acute myocardial Infarction: Insights from the J-PCI registry. Am J Cardiol. 2023;192:182-9.
    
    
28. Saito Y, Inohara T, Kohsaka S, Wada H, Takamisawa I, Yamaji K, Amano T, Kobayashi Y, Kozuma K, J-PCI Registry Investigators. Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry. Am Heart J. 2023;258:69-76.
    
    
27. Saito Y, Kobayashi Y. Complete revascularization in acute myocardial infarction: A clinical review. Cardiovasc Interv Ther. 2023;38:177-86.
    
    
26. Saito Y, Hashimoto O, Nakayama T, Sasaki H, Yumoto K, Oshima S, Tobaru T, Kushida S, Kanda J, Sakai Y, Okino S, Fukuzawa S, Abiko A, Itoh T, Nakamura Y, Nakashima T, Yasuda S, Goto K, Takebayashi H, Oshitomi T, Sakamoto T, Kojima S, Otsuka Y, Himi T, Inagaki Y, Yamaguchi J, Hagiya K, Nanasato M, Kobayashi Y. Right versus left coronary artery involvement in patients with type A acute aortic dissection. Int J Cardiol. 2023;371:49-53.
    
    
25. Saito Y, Oyama K, Tsujita K, Yasuda S, Kobayashi Y. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. J Cardiol. 2023;81:168-78.
    
    
24. Saito K, Saito Y, Kitahara H, Kobayashi Y. Impact of myocardial bridge on non-culprit vessel atherosclerosis in patients with acute coronary syndrome. Heart Vessels. 2023;38:32-9.
    
    
23. Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients With Acute Myocardial Infarction. J Atheroscler Thromb. 2023;30:299-309.
    
    
22. Tateishi K, De Gregorio J. Thrombectomy of right atrial thrombus for an elderly patient. Cardiovasc Interv Ther. 2023 Apr;38(2):260-261.
    
    
21. Tateishi K, Asselin CY, Elmann EM, De Gregorio J. Delayed Aortic Valve Perforation Caused by Blunt Trauma. Diagnostics (Basel). 2023 Feb 2;13(3):549.
    
    
20. Tateishi K, Hastings R, De Gregorio J. Percutaneous management of a connection due to annular rupture after transcatheter aortic valve replacement. Cardiovasc Interv Ther. 2023 Jul;38(3):352-353.
    
    
19. Tateishi K, Saito Y, Kitahara H, Shiko Y, Kawasaki Y, Nonogi H, Tahara Y, Yonemoto N, Nagao K, Ikeda T, Sato N, Kobayashi Y; Japanese Circulation Society Resuscitation Science Study JCS-ReSS Group. Impact of number of defibrillation attempts on neurologically favourable survival rate in patients with Out-of-Hospital cardiac arrest. Resuscitation. 2023 May;186:109779.
    
    
18. Tateishi K, Saito Y, Yasufuku Y, Nakagomi A, Kitahara H, Kobayashi Y, Tahara Y, Yonemoto N, Ikeda T, Sato N, Okura H. Prehospital predicting factors using a decision tree model for patients with witnessed out-of-hospital cardiac arrest and an initial shockable rhythm. Sci Rep. 2023 Sep 27;13(1):16180.
    
    
17. Sato T, Saito Y, Kitahara H, Kobayashi Y. Relation of GRACE Risk Score to Coronary Lipid Core Plaques in Patients with Acute Coronary Syndrome. Life (Basel). 2023 Feb 24;13(3):630.
    
    
16. Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction. J Atheroscler Thromb. 2023;30:299-309.
    
    
15. Matsumoto T, Kitahara H, Yamazaki T, Hiraga T, Yamashita D, Sato T, Saito Y,　Kato K, Kobayashi Y. Very short-term tissue coverage of the CD34 antibody-covered sirolimus-eluting stent: an optical coherence tomography study. Cardiovasc Interv Ther. 2023 Oct;38(4):381-387.
    
    
14. Yamashita D, Saito Y, Sato T, Matsumoto T, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Impact of Denture Use on Ischemic and Bleeding Outcomes of Patients with Acute Myocardial Infarction. Intern Med. 2023 May 1;62(9):1251-1257.
    
    
13. Yamashita D, Kitahara H, Saito Y, Kato K, Kobayashi Y. Coronary Artery Perforation After Balloon Dilatation for Recurrent In-Stent Restenosis Inside the Double-Layered Previous Stents. JACC Case Rep. 2023 Aug 5;21:101976.
    
    
12. Yamazaki T, Saito Y, Yamashita D, Kitahara H, Kobayashi Y. Validation of pressure-bounded coronary flow reserve using invasive coronary physiologic assessment. Heart Vessels. 2023 May;38(5):626-633.
    
    
11. Yamazaki T, Saito Y, Yamashita D, Kitahara H, Kobayashi Y. Factors Associated with Impaired Resistive Reserve Ratio and Microvascular Resistance Reserve. Diagnostics (Basel). 2023 Mar 2;13(5):950.
    
    
10. Yamazaki T, Okada S, Saito Y, Kitahara H, Kobayashi Y. ST-Segment Elevation Myocardial Infarction in a 32-Year-Old Man With a History of Incomplete Kawasaki Disease. JACC Case Rep. 2023 May 8;15:101851.
    
    
9. Yamazaki T, Saito Y, Yamashita D, Kitahara H, Kobayashi Y. Impact of preceding acetylcholine provocation testing on following coronary physiological assessment during an interventional diagnostic procedure. J Cardiol. 2023 Sep;82(3):215-219.
   
   
8. Hiroki Goto, Yuichi Saito, Tadahiro Matsumoto, Takanori Sato, Daichi Yamashita, Sakuramaru Suzuki ,Shinichi Wakabayashi , Hideki Kitahara1, Koichi Sano and Yoshio Kobayashi. Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel. J Atheroscler Thromb. 2023 Dec 1;30(12):1791-1802.
   
   
7. Kazunari Asada, Yuichi Saito, Takanori Sato, Tadahiro Matsumoto, Daichi Yamashita, Sakuramaru Suzuki, Shinichi Wakabayashi, Hideki Kitahara, Koichi Sano, Yoshio Kobayashi. Prognostic Value of Natriuretic Peptide Levels and In-Hospital Heart Failure Events in Patients With Acute Myocardial Infarction. Circ J. 2023;87:640-647.
   
   
6. Hiroaki Yaginuma, Yuichi Saito, Takanori Sato, Daichi Yamashita, Tadahiro Matsumoto, Sakuramaru Suzuki, Shinichi Wakabayashi, Hideki Kitahara, Koichi Sano, Yoshio Kobayashi. Clinical characteristics and outcomes of patients with chronic systemic inflammatory disease in acute myocardial infarction. PLoS One. 2023 Aug 24;18(8):e0289794.
   
   
5. Saito Y, Oyama K, Tsujita K, Yasuda S, Kobayashi Y. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. J Cardiol. 2023 Feb;81(2):168-178.
   
   
4. Saito K, Saito Y, Kitahara H, Kobayashi Y. Impact of myocardial bridge on non-culprit vessel lumen changes in patients with acute coronary syndrome. Heart Vessels. 2023 Jan;38(1):32-39.
   
   
3. Kobayashi T, Kitahara H, Kato K, Saito Y, Kobayashi Y. Impact of Parathyroid Hormone Level on Intracoronary Calcification and Short- and Long-erm Outcomes in Dialysis Patients Undergoing Percutaneous Coronary Intervention. Circ J. 2023 Jan 25;87(2):247-255.
   
   
2. Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients With Acute Myocardial Infarction. J Atheroscler Thromb. 2023 Mar 1;30(3):299-309.
   
   
1. Yamashita D, Saito Y,Sato T，Matsumoto T, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y．Impact of dentures on ischemic and bleeding outcomes in patients with acute myocardial infarction. Intern Med. 2023 May 1;62(9):1251-1257.

2022年

63. Nickenig G. Sugiura A. Transcatheter tricuspid annulus reconstruction: compelling and complex. JACC Cardiovasc Interv. 2022 Oct 10;15(19):1933-1935.
    
    
62. Mauri V, Sugiura A, Spieker M, Iliadis C, Horn P, Öztürk C, et al. Early Outcomes of 2 Mitral Valve Transcatheter Leaflet Approximation Devices: A Propensity Score-Matched Multicenter Comparison. JACC Cardiovasc Interv. 2022 Dec 26;15(24):2541-2551.
    
    
61. Saito Y, Deguchi Y, Nakao M, Shiraishi H, Sakamoto N, Kobayashi S, Kobayashi Y. Predictivity of acute kidney injury risk scores for late kidney injury in patients with chronic coronary syndrome. Heart Vessels. 2022;37:1971-6.
    
    
60. Tateishi K, Kondo Y, Saito Y, Kitahara H, Fukushima K, Takahashi H, Yamashita D, Ohashi K, Suzuki K, Hashimoto O, Sakai Y, Kobayashi Y. Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study. PLoS One. 2022 Oct 31;17(10):e0277034.
    
    
59. Sato T, Saito Y, Suzuki S, Matsumoto T, Yamashita D, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Prognostic factors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock. Life (Basel). 2022 Oct 21;12(10):1672.
    
    
58. Hiraga T, Saito Y, Tateishi K, Kitahara H, Kobayashi Y. Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Croronary Artery Disease. Medicina. 2022 Oct 10;58(10):1423.
    
    
57. Kayo Yamamoto, Ryohei Ono, Ryo Ito, Yoshio Kobayashi. Blow-out left ventricular free wall rapture. Eur Heart J Case Rep. 2022 Nov 29;6(12):ytac456.
    
    
56. Kitahara H, Yamazaki T, Hiraga T, Yamashita D, Matsumoto T, Kobayashi T, Sato T, Suzuki M, Saito K, Matsuoka T, Mori N, Tateishi K, Fujimoto Y, Kobayashi Y. Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease. J Cardiol. 2022;79:559-563.
    
    
55. Kitahara H, Tateishi K, Shiko Y, Inaba Y, Kobayashi Y, Inoue T. Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention. PLoS One. 2022;17:e0272140.
    
    
54. Kitahara H. How Can We Prevent Both Bleeding and Ischemic Events After Percutaneous Coronary Intervention in High-Bleeding Risk Patients? Circ J. 2022;86:1362-1364.
    
    
53. Nickenig G, Sugiura A. Transcatheter tricuspid annulus reconstruction: compelling and complex. JACC Cardiovasc Interv. 2022;15:1933-1935.
    
    
52. Tanaka T, Sugiura A, Öztürk C, Vogelhuber J, Tabata N, Wilde N, Zimmer S, Nickenig G, Weber M. Transcatheter edge-to-edge repair for atrial secondary mitral regurgitation. JACC Cardiovasc Interv. 2022;15:1731-1740.
    
    
51. Sugiura A, Kavsur R, Spieker M, Iliadis C, Mauri V, Tanaka T, Goto T, Weber M, Kelm M, Baldus S, Nickenig G, Westenfeld R, Pfister R, Becher MU. Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation. EuroIntervention. 2022 Nov 18;18(10):852-861.
    
    
50. Sugiura A, Sudo M, Al-Kassou B, Shamekhi J, Silaschi M, Wilde N, Sedaghat A, Becher UM, Weber M, Sinning JM, Grube E, Nickenig G, Charitos EI, Zimmer S. Percutaneous trans-axilla transcatheter aortic valve replacement. Heart Vessels. 2022;37:1801-1807.
    
    
49. Tanaka T, Sugiura A, Kavsur R, Vogelhuber J, Öztürk C, Becher MU, Zimmer S, Nickenig G, Weber M. Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair. EuroIntervention. 2022;18:e169-e178.
    
    
48. Sugiura A, Kavsur R, Spieker M, Iliadis C, Goto T, Öztürk C, Weber M, Tabata N, Zimmer S, Sinning JM, Mauri V, Horn P, Kelm M, Baldus S, Nickenig G, Westenfeld R, Pfister R, Becher MU. Recurrent mitral regurgitation after edge-to-edge mitral repair: predictor, etiology, and clinical impact. Circulation Cardiovasc Interv. 2022;15:e010895.
    
    
47. Sudo M, Sugiura A, Treiling L, Al-Kassou B, Shamekhi J, Kuetting D, Wilde N, Weber M, Zimmer S, Nickenig G, Sedaghat A. Pulmonary artery dilatation and its clinical implication in patients undergoing transcatheter aortic valve replacement. Int J Cardiol. 2022;348:26-32.
    
    
46. Shamekhi J, Sugiura A, Spieker M, Iliadis C, Weber M, Öztürk C, Becher MU, Tiyerili V, Zimmer S, Horn P, Westenfeld R, Pfister R, Mauri V, Sinning JM, Kelm M, Baldus S, Nickenig G. A staging classification of right heart remodeling for patients undergoing transcatheter edge-to-edge mitral valve repair. EuroIntervention. 2022;18:43-49.
    
    
45. Okamoto H, Nishi T, Ishii M, Tsujita K, Koto S, Nakai M, Sumita Y, Iwanaga Y, Matoba S, Kobayashi Y, Hirata KI, Hikichi Y, Yokoi H, Ikari Y, Uemura S. Clinical Characteristics and Outcomes of Patients Presenting With Acute Myocardial Infarction Without Cardiogenic Shock. Circ J. 2022 Sep 22;86(10):1527-1538.
    
    
44. Nishi T, Ishii M, Tsujita K, Okamoto H, Koto S, Nakai M, Sumita Y, Iwanaga Y, Matoba S, Kobayashi Y, Hirata KI, Hikichi Y, Yokoi H, Ikari Y, Uemura S. Outcomes of Venoarterial Extracorporeal Membrane Oxygenation Plus Intra-Aortic Balloon Pumping for Treatment of Acute Myocardial Infarction Complicated by Cardiogenic Shock. J Am Heart Assoc. 2022;11:e023713.
    
    
43. Nishi T, Kume T, Yamada R, Okamoto H, Koto S, Yamashita M, Ueno M, Kamisaka K, Sasahira Y, Enzan A, Sudo Y, Tamada T, Koyama T, Imai K, Neishi Y, Uemura S. Layered Plaque in Organic Lesions in Patients With Coronary Artery Spasm. J Am Heart Assoc. 2022;11:e024880.
    
    
42. Khan MO, Nishi T, Imura S, Seo J, Wang H, Honda Y, Nieman K, Rogers IS, Tremmel JA, Boyd J, Schnittger I, Marsden A. Colocalization of Coronary Plaque with Wall Shear Stress in Myocardial Bridge Patients. Cardiovasc Eng Technol. 2022 Oct;13(5):797-807.
    
    
41. Nishi T, Kume T, Yamada R, Okamoto H, Neishi Y, Uemura S. Rapid Plaque Progression Possibly Due to Intraplaque Hemorrhage in a Patient With Coronary Artery Spasm. Circ J. 2022;86:1309.
    
    
40. Kume T, Nishi T, Murasato Y, Koto S, Yamada R, Koyama T, Tamada T, Imai K, Okamoto H, Neishi Y, Uemura S. Comparative bifurcation bench analysis of three different optimization procedures after main branch stent implantation. Coron Artery Dis. 2022;33:499-501.
    
    
39. Kang DY, Ahn JM, Kim JB, Yeung A, Nishi T, Fearon W, Cantey EP, Flaherty JD, Davidson CJ, Malaisrie SC, Park SY, Yun SC, Ko E, Park H, Lee SA, Kim DH, Kim HJ, Kim JB, Choo SJ, Park DW, Park SJ. Inter-racial differences in patients undergoing transcatheter aortic valve implantation. Heart. 2022 Sep 12;108(19):1562-1570.
    
    
38. Takahashi T, Nishi T, Zimmermann FM, Granada JF, Latib A, Fearon WF, Kobayashi Y. Clinical validation of a novel simplified offline tool for SYNTAX score calculation. Catheter Cardiovasc Interv. 2022;99:1366-1368.
    
    
37. Kato K, Daimon M, Sano M, Matsuno K, Sakai Y, Ishibashi I, Kadohira T, Matsumoto K, Masuda Y, Uno T, Ghadri JR, Templin C, Kobayashi Y. Dynamic Trend of Myocardial Edema in Takotsubo Syndrome: A Serial Cardiac Magnetic Resonance Study. J Clin Med. 2022;11:987.
    
    
36. Isogai T, Kato K. β-blockers and outcomes of Takotsubo syndrome: need more clinical data. Heart. 2022 Aug 11;108(17):1334-1337.
    
    
35. Saito Y, Tanaka A, Koide Y, Yoshida H, Uchida D, Matsunaga K, Yokota N, Ueyama C, Kobayashi Y, Node K, and for the PRIZE Study Investigators. Impact of febuxostat on visit-to-visit blood pressure variability: Insights from the randomized PRIZE study. RMD Open. 2022;8:e002505.
    
    
34. Saito Y, Deguchi Y, Nakao M, Shiraishi H, Sakamoto N, Kobayashi S, Kobayashi Y. Predictivity of acute kidney injury risk scores for late kidney injury in patients with chronic coronary syndrome. Heart Vessels. 2022 Dec;37(12):1971-1976.
    
    
33. Nakano S, Kohsaka S, Chikamori T, Fukushima K, Kobayashi Y, Kozuma K, Manabe S, Matsuo H, Nakamura M, Ohno T, Sawano M, Tada K, Ueda Y, Yokoi H, Gatate Y, Kasai T, Kawase Y, Matsumoto N, Mori H, Nakazato R, Niimi N, Saito Y, Shintani A, Watanabe I, Watanabe Y, Ikari Y, Jinzaki M, Kosuge M, Nakajima K, Kimura T on behalf of the JCS Joint Working Group. JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease. Circ J. 2022;86:882-915.
    
    
32. Saito Y, Nishi T, Kato K, Kitahara H, Kobayashi Y. Resistive Reserve Ratio and Microvascular Resistance Reserve in Patients With Coronary Vasospastic Angina. Heart Vessels. 2022;37:1489-1495.
    
    
31. Saito Y, Tateishi K, Kanda M, Shiko Y, Kawasaki Y, Kobayashi Y, Inoue T. Volume-Outcome Relationships for Percutaneous Coronary Intervention in Acute Myocardial Infarction. J Am Heart Assoc. 2022;11:e023805.
    
    
30. Gitto M, Saito Y, Taoutel R, Schneider M, Papoutsidakis N, Ardito S, McCarthy M, Cristea E, Lansky AJ, Altin SE. Angiographic Lesion Discordance in Women Presenting With Ischemic Heart Disease: Comparison of Visual Assessment, Quantitative Coronary Angiography, and Quantitative Flow Ratio. J Invasive Cardiol. 2022;34:E202-E209.
    
    
29. Saito Y, Saito Y, Kato K, Kobayashi Y. Gender differences in factors associated with vasospastic angina. Int J Cardiol. 2022;349:7-11.
    
    
28. Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Derivation of Novel Scoring System Predicting High Platelet Reactivity on Prasugrel in Patients With Coronary Artery Disease. J Atheroscler Thromb. 2022 Nov 1;29(11):1625-1633.
    
    
27. Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Honye J. Clinical expert consensus document on intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics (2021). Cardiovasc Interv Ther. 2022;37:40-51.
    
    
26. Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Coronary Artery Disease Patients Treated with Clopidogrel and Prasugrel. J Atheroscler Thromb. 2022;29:1031-1039.
    
    
25. Saito Y, Nishi T, Saito K, Kitahara H, Kawase Y, Matsuo H, Kobayashi Y. Clinical Implications and Debates on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches Trial. Cardiol Rev. 2022;30:234-240.
    
    
24. Saito Y, Wijns W, Baumbach A, Xu B, Kelbæk H, Zheng M, Morel M, Anderson R, Schächinger V, Lansky A. Differential Impact of Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent on and off Dual Antiplatelet Therapy. Catheter Cardiovasc Interv. 2022;99:357-365.
    
    
23. De Gregorio J, Tateishi K. Un-Dilatable In-Stent Restenosis: An Ounce of Prevention…. Cardiovasc Revasc Med. 2022;34:38-39.
    
    
22. Tateishi K, Saito Y, Kitahara H, Kobayashi Y. Impact of glycemic variability on coronary and peripheral endothelial dysfunction in patients with coronary artery disease. J Cardiol. 2022;79:65-70.
    
    
21. Tateishi K, Saito Y, Kitahara H, Kobayashi Y. Relation of glucose variability to vulnerable plaque formation in patients with coronary arterydisease. Heart Vessels. 2022;37:1516-1525.
    
    
20. Tateishi K, Saito Y, Matsuoka T, Kitahara H, Kobayashi Y. Layered coronary plaque associated with coronary vasospasm. Cardiovasc Interv Ther. 2022;37:389-390.
    
    
19. Tateishi K, Saito Y, Yamazaki T, Kitahara H, Kobayashi Y. Impact of In-Hospital Versus Ambulatory Glucose Variability on Coronary Plaque Vulnerability in Patients With Coronary Artery Disease. Diabet Epidemiol Manag. 2022;8:100104.
    
    
18. Okuya Y, Moussa ID. Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters! Catheter Cardiovasc Interv. 2022;99:169-170.
    
    
17. Okuya Y, Gohil K, Moussa ID. Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis. Catheter Cardiovasc Interv. 2022;100:340-350.
    
    
16. Saito K, Kitahara H, Matsuoka T, Mori N, Tateishi K, Fujimoto Y, Kobayashi Y. Influence of myocardial bridge on atherosclerotic plaque distribution and characteristics evaluated by near-infrared spectroscopy intravascular ultrasound. Heart Vessels. 2022;37:1701-1709.
    
    
15. Saito K, Saito Y, Muramatsu T, Kitahara H, Fujimoto Y, Isono S, Kobayashi Y. Impact of perioperative antithrombotic strategies on clinical events in non-cardiac surgery. Heart Vessels. 2022;37:1337-1343.
    
    
14. Sato T, Saito Y, Matsumoto T, Yamashita D, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. In-hospital adverse events in low-risk patients with acute myocardial infarction – Potential implications for earlier discharge. J Cardiol. 2022;79:747-751.
    
    
13. Yamashita D, Saito Y, Sato T, Matsumoto T, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Impact of PARIS and CREDO-Kyoto Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients with Acute Myocardial Infarction. Circ J. 2022;86:622-629.
    
    
12. Yamazaki T, Saito Y, Kobayashi T, Kitahara H, Kobayashi Y. Factors associated with discordance between fractional flow reserve and resting full-cycle ratio. J Cardiol. 2022;80:9-13.
    
    
11. Yamazaki T, Nishi T, Saito Y, Tateishi K, Kato K, Kitahara H, Kobayashi Y. Discrepancy between plaque vulnerability and functional severity of angiographically intermediate coronary artery lesions. Cardiovasc Interv Ther. 2022;37:691-698.
    
    
10. Yamazaki T, Saito Y, Kobayashi T, Kitahara H, Kobayashi Y. Relation of hyperemic response during fractional flow reserve measurement to coronary flow reserve. J Cardiol. 2022 Dec;80(6):532-536.
    
    
9. Suzuki S, Saito Y, Yamashita D, Matsumoto T, Sato T, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Clinical characteristics and prognosis of patients with no standard modifiable risk factors in acute myocardial infarction. Heart Lung Circ. 2022;31:1228-1233.
   
   
8. Yamashita D, Saito Y, Sato T, Matsumoto T, Saito K, Wakabayashi, S, Kitahara H, Sano K, Kobayashi Y. Impact of PARIS and CREDO-Kyoto Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients with Acute Myocardial Infarction. Circ J. 2022;86:622-629.
   
   
7. Tateishi K, Saito Y, Matsuoka T, Kitahara H, Kobayashi Y. Layered coronary plaque associated with coronary vasospasm. Cardiovasc Interv Ther. 2022 Apr;37(2):389-390.
   
   
6. Sugiura A et al. Early response of right ventricular function following transcatheter mitral valve repair. Clin Res Cardiol. 2022 Aug;111(8):859-868.
   
   
5. Imori Y*, Kato K* (*First two authors equally contributed to this work), Cammann VL, Szawan KA, Wischnewsky M, Dreiding S, et al. Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry. Clin Res Cardiol. 2022 Feb;111(2):186-196.
   
   
4. Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Coronary Artery Disease Patients Treated with Clopidogrel and Prasugrel. J Atheroscler Thromb. 2022 Jul 1;29(7):1031-1039.
   
   
3. Saito Y, Nishi T, Saito K, Kitahara H, Kawase Y, Matsuo H, Kobayashi Y. Clinical implications and debates on the ISCHEMIA trial. Cardiol Rev. 2022 Sep-Oct;30(5):234-240.
   
   
2. Saito Y, Wijns W, Baumbach A, Xu B, Kelbæk H, Zheng M, Morel M, Anderson R, Schächinger V, Lansky A. Differential Impact of Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent on and off Dual Antiplatelet Therapy. Catheter Cardiovasc Interv. 2022 Feb;99(2):357-365.
   
   
1. Tateishi K, Saito Y, Kitahara H, Kobayashi Y. Impact of glycemic variability on coronary and peripheral endothelial dysfunction in patients with coronary artery disease. J Cardiol. 2022 Jan;79(1):65-70.

2021年

49. Oh JH, Kobayashi Y, Kang G, Nishi T, Willemink MJ, Fearon WF, Fischbein M, Fleishmann D, Yeung AC, Kim JB. Distance between valvular leaflet and coronary ostium predicting risk of coronary obstruction during TAVR. Int J Cardiol Heart Vasc. 2021;37:100917.

48. Park H, Ahn JM, Kang DY, Kim JB, Yeung AC, Nishi T, Fearon WF, Cantey EP, Flaherty JD, Davidson CJ, Malaisrie SC, Kim S, Yun SC, Ko E, Lee SA, Kim DH, Kim HJ, Kim JB, Choo SJ, Park DW, Park SJ. Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2021;14:2670-2681.

47. Wong CCY, Nishi T, Yong ASC, Murai T, Kakuta T, Waseda K, Amano T, Hirohata A, Barbato E, Ng MKC, Fearon WF. Discordance Between the Index of Microcirculatory Resistance and Coronary Flow Reserve After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2021;14:2412-2414.

46. Hashikata T, Honda Y, Wang H, Pargaonkar VS, Nishi T, Hollak MB, Rogers IS, Nieman K, Yock PG, Fitzgerald PJ, Schnittger I, Boyd JH, Tremmel JA. Impact of Diastolic Vessel Restriction on Quality of Life in Symptomatic Myocardial Bridging Patients Treated With Surgical Unroofing: Preoperative Assessments With Intravascular Ultrasound and Coronary Computed Tomography Angiography. Circ Cardiovasc Interv. 2021;14:e011062.

45. Okuya Y, Moussa ID. Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon! Catheter Cardiovasc Interv. 2021;98:786-787.

44. Matsumoto T, Saito Y, Yamashita D, Sato T, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Impact of Active and Historical Cancer on Short- and Long-Term Outcomes in Patients With Acute Myocardial Infarction. Am J Cardiol. 2021;159:59-64.

43. Ishii M, Tsujita K, Okamoto H, Koto S, Nishi T, Nakai M, Sumita Y, Iwanaga Y, Azuma N, Matoba S, Hirata K, Hikichi Y, Yokoi H, Ikari Y, Uemura S. Resources for Cardiovascular Healthcare associated with 30-day Mortality in Acute Myocardial Infarction with Cardiogenic Shock. Eur Heart J Open. 2021 Dec 31;2:oeab047.

42. Kitahara H, Kobayashi Y. Transcatheter interventions for valvular heart disease: An up-to-date overview of transcatheter aortic valve implantation and transcatheter mitral valve repair. J Clin Physiol 2021;51:73-77.

41. Sugiura A. Tanaka T, Kavsur R, Oeztuerk C, Vogelhuber J, Wilde N, Becher MU, Zimmer S, Nickenig G, Weber M. Leaflet configuration and residual tricuspid regurgitation after transcatheter edge-to-edge tricuspid repair. JACC Cardiovasc Intervention. 2021;14:2260-2270.

40. Sugiura A, Treiling L, Al-Kassou B, Shamekhi J, Wilde N, Sinning JM, Zimmer S, Kuetting D, Oldenburg J, Poetzsch B, Nickenig G, Sedaghat A. Spleen and thrombocytopenia after transcatheter aortic valve replacement. Am J Cardiol. 2021;157:85-92.

39. Sugiura A, Wilde N, Weber M, Vogelhuber J, Zimmer S, Grube E, Nickenig G. Transcatheter triple-valve intervention. JACC Cardiovasc Intervention. 2021;14(14):e179-e181.

38. Sugiura A, Weber M, Tabata N, Goto T, Oeztuerk C, Lin M, Nickenig G, Sinning JM. QRS duration is a risk indicator of adverse outcomes after MitraClip. Catheter Cardiovasc Interv. 2021;98(4):E594-E601.

37. Sugiura A, Vogelhuber J, Öztürk C, Schwaibold Z, Reckers D, Goto T, Kavsur R, Becher MU, Zimmer S, Nickenig G, Weber M. PASCAL versus MitraClip-XTR edge-to-edge device for the treatment of tricuspid regurgitation: A propensity-matched analysis. Clin Res Cardiol. 2021;110(3):451-459.

36. Öztürk C, Sprenger K, Tabata N, Sugiura A, Weber M, Nickenig G, Schueler R. The predictive value of intraprocedural mitral gradient for outcomes after MitraClip and its peri-interventional dynamics. Echocardiography. 2021 Jul;38(7):1115-1124.

35. Tanaka T, Kavsur R, Sugiura A, Vogelhuber J, Öztürk C, Weber M, Tiyerili V, Zimmer S, Nickenig G, Becher MU. Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair. Sci Rep. 2021 Jul 13;11(1):14420.

34. Voigtländer L, Kim WK, Mauri V, Goßling A, Renker M, Sugiura A, Linder M, Schmidt T, Schofer N, Westermann D, Reichenspurner H, Nickenig G, Blankenberg S, Hamm C, Conradi L, Adam M, Sinning JM, Seiffert M. Transcatheter aortic valve implantation in patients with a small aortic annulus: performance of supra-, intra- and infra-annular transcatheter heart valves. Clin Res Cardiol. 2021 Dec;110(12):1957-1966.

33. Tanaka T, Kavsur R, Spieker M, Iliadis C, Metze C, Horn P, Sugiura A, Baldus S, Kelm M, Nickenig G, Pfister R, Westenfeld R, Becher MU. Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair. Clin Res Cardiol. 2021 Dec;110(12):1947-1956.

32. Witberg G, Codner P, Landes U, Schwartzenberg S, Barbanti M, Valvo R, De Backer O, Ooms JF, Islas F, Marroquin L, Sedaghat A, Sugiura A, et al. Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality. JACC cardiovascular interventions 2021;14(11):1181-1192.

31. Hatim Seoudy, Baravan Al-Kassou, Jasmin Shamekhi, Atsushi Sugiura, et al. Frailty in patients undergoing transcatheter aortic valve replacement: prognostic value of the Geriatric Nutritional Risk Index. J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):577-585.

30. Mitsunobu Kitamura, Neil P Fam, Daniel Braun, Tobias Ruf, Atsushi Sugiura, Akhil Narang, et al. 12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation. Catheter Cardiovasc Interv. 2021 May 1;97(6):1281-1289.

29. Nishi T, Imura S, Kitahara H, Kobayashi Y, Yock PG, Fitzgerald PJ, Honda Y. Head-to-head comparison of quantitative measurements between intravascular imaging systems: An in vitro phantom study. Int J Cardiol Heart Vasc. 2021 Sep 1;36:100867.

28. Nishi T, Murai T, Waseda K, Hirohata A, Yong ASC, Ng MKC, Amano T, Barbato E, Kakuta T, Fearon WF. Association of microvascular dysfunction with clinical outcomes in patients with non-flow limiting fractional flow reserve after percutaneous coronary intervention. Int J Cardiol Heart Vasc. 2021 Jul 14;35:100833.

27. Nishi T, Okada K, Kitahara H, Kameda R, Ikutomi M, Imura S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Ellis SG, Kereiakes DJ, Stone GW, Honda Y, Kimura T; ABSORB III and ABSORB Japan Investigators. Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials. J Cardiol. 2021 Sep;78(3):224-229.

26. Nishi T, Yamashita R, Imura S, Tateishi K, Kitahara H, Kobayashi Y, Yock PG, Fitzgerald PJ, Honda Y. Deep learning-based intravascular ultrasound segmentation for the assessment of coronary artery disease. Int J Cardiol. 2021;333:55-59.

25. Nishi T, Saito Y, Kitahara H, Nishi T, Fujimoto Y, Kobayashi Y. Coronary Flow Reserve and Glycemic Variability in Patients with Coronary Artery Disease. Intern Med. 2021;60:1151-1158.

24. Kato K, Cammann VL, Napp LC, Szawan KA, Micek J, Dreiding S, et al. Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry. ESC Heart Fail. 2021;8:1924-1932.

23. Saito Y. Review of the ISCHEMIA Trial. J Clin Physiol. 2021;51:79-82.

22. Hashimoto O, Saito Y, Nakayama T, Okino S, Sakai Y, Nakamura Y, Fukuzawa S, Himi T, Ishibashi I, Kobayashi Y. Impact of Branch Vessel Involvement on Computed Tomography Versus Clinical Presentation of Malperfusion in Patients with Type A Acute Aortic Dissection. Am J Cardiol. 2021;152:158-63

21. Saito Y, Kobayashi Y. Academic Research Consortium Definition of High Bleeding Risk in Clinical Practice ― Validation and Beyond ―. Circ J. 2021;85:806-7.

20. Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: A clinical review. J Cardiol. 2021;78:51-7.

19. Okuya Y, Saito Y, Kobayashi Y. IVUS tells a potential of late lumen enlargement after CTO PCI: The story so far. Cardiovasc Revasc Med. 2021;25:18-9.

18. Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Validation of the ABCD-GENE Score to Identify High Platelet Reactivity in East Asian Patients Undergoing Percutaneous Coronary Intervention. Int J Cardiol. 2021;327:15-8.

17. Saito Y, Mori N, Murase T, Nakamura T, Akari S, Saito K, Matsuoka T, Tateishi K, Kadohira T, Kitahara H, Fujimoto Y, Kobayashi Y. Greater coronary lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound in patients with elevated xanthine oxidoreductase: A mechanistic insight. Heart Vessels. 2021;36:597-604.

16. Saito Y, Kobayashi Y. Contemporary Coronary Drug-Eluting and Coated Stents: A Mini-Review. Cardiovasc Interv Ther. 2021;36:20-2.

15. Okuya, Y, Saito Y, Takahashi T, Kishi K. Impact of Myocardial Bridge on Late Lumen Enlargement in Distal Reference Segments After Recanalization of Coronary Chronic Total Occlusion. Int J Cardiovasc Imaging. 2021;37:775-82.

14. Saito Y, Kelbæk H, Xu B, Hussain Y, Anderson R, Schächinger V, Zheng M, Wijns W, Baumbach A, Lansky A. Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent: 3-Year Results of the TARGET All Comers Trial. EuroIntervention. 2021;17:e332-4.

13. Saito Y, Cristea E, Bouras G, Abizaid A, Lutz M, Carrié D, Weber-Albers J, Dudek D, Anderson J, Lansky A. Long-Term Serial Functional Evaluation After Implantation of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold. Catheter Cardiovasc Interv. 2021;97:431-6.

12. Tateishi K, Kitahara H, Saito Y, Kadohira T, Saito K, Matsuoka T, Mori N, Nakayama T, Fujimoto Y, Kobayashi Y. Impact of clinical presentations on lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound. Int J Cardiovasc Imaging. 2021;37:1151-1158.

11. Saito K, Kondo Y, Takahashi M, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Factors that predict ventricular arrhythmias in the late phase after acute myocardial infarction. ESC Heart Fail 2021;8:4152-4160.

10. Matsuoka T, Kitahara H, Saito K, Mori N, Tateishi K, Fujimoto Y, KobayashiY. Department of Cardiovascular Medicine Utility of near-infrared spectroscopy to detect the extent of lipid core plaque leading to periprocedural myocardial infarction. Catheter Cardiovasc Interv. 2021 Nov 1;98(5):E695-E704.

9. Sato T, Saito Y, Matsumoto T, Yamashita D, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Impact of CADILLAC and GRACE risk scores on short- and long-term clinical outcomes in patients with acute myocardial infarction. J Cardiol. 2021;78:201–205.

8. Matsumoto T, Saito Y, Saito K, Tateishi K, Kato K, Kitahara H, Kobayashi Y. Relation between cancer and vasospastic angina. Adv Ther. 2021 Aug;38(8):4344-4353.

7. Matsumoto T, Saito Y, Yamashita D, Sato T, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Impact of Active and Historical Cancer on Short- and Long-Term Outcomes in Patients With Acute Myocardial Infarction. Am J Cardiol. 2021;159:59-64.

6. Hiraga T, Saito Y, Mori N, Tateishi K, Kitahara H, Kobayashi Y. Impact of Serum Uric Acid Level on Systemic Endothelial Dysfunction in Patients With a Broad Spectrum of Ischemic Heart Disease. J Clin Med. 2021;10(19):4530.

5. Tateishi K, Saito Y, Kitahara H, Takaoka H, Kondo Y, Nakayama T, Fujimoto Y, Kobayashi Y. Vasospastic angina and overlapping cardiac disorders in patients resuscitated from cardiac arrest. Heart Vessels. 2021 Mar;36(3):321-329.
   
   
4. Deguchi Y, Saito Y, Nakao M, Shiraishi H, Sakamoto N, Kobayashi S, Kobayashi Y. Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease. Heart Vessels. 2021 Mar;36(3):315-320.
   
   
3. Wolff G, Shamekhi J, Al-Kassou B, Tabata N, Parco C, Klein K, Maier O, Sedaghat A, Polzin A, Sugiura A, Jung C, Grube E, Westenfeld R, Icks A, Zeus T, Sinning JM, Baldus S, Nickenig G, Kelm M, Veulemans V. Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients. Clin Res Cardiol. 2021 Mar;110(3):368-376.
   
   
2. Sugiura A, Wilde N, Sedaghat A, Becher MU, Kelm M, Baldus S, Nickenig G, Veulemans V, Tiyerili V. Risk of mortality following transcatheter aortic valve replacement for low-flow low-gradient aortic stenosis. Clin Res Cardiol. 2021 Mar;110(3):391-398.
   
   
1. Sugiura A, Weber M, Tabata N, Goto T, Treede H, Grube E, Werner N, Nickenig G, Sinning JM. Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation. Catheter Cardiovasc Interv. 2021;98(3):E412-E419.

2020年

38. Tateishi K, Nakagomi A, Saito Y, Kitahara H, Kanda M, Shiko Y, Kawasaki Y, Kuwabara H, Kobayashi Y, Inoue T. Feasibility of management of hemodynamically stable patients with acute myocardial infarction following primary percutaneous coronary intervention in the general ward settings. PLoS One. 2020;15:e0240364.

37. Saito Y, Baumbach A, Wijns W, Xu B, Kelbæk H, Zheng M, Morel M, Anderson R, Schächinger V, Lansky A. Clinical Outcomes of Complex Lesions Treated with an Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent. Catheter Cardiovasc Interv. 2020;96:1023-8.

36. Kang G, Sarraju A, Nishi T, Rogers I, Tremmel JA, Kim JB. Spontaneous coronary artery dissection and ST-elevation myocardial infarction in an anomalous left anterior descending artery. JACC: Case Reports. 2020 ; 2 (1), 72-76.
    
    
35. Daniels D, Pargaonkar V, Nishi T, Tremmel JA. Antegrade Dissection Re-Entry After Subintimal Wiring of an Occluded Vessel from Spontaneous Coronary Artery Dissection. JACC: Case Reports.2020 ;2 (1), 45-50.
    
    
34. Pargaonkar VS, Lee JH, Chow EKH, Nishi T, Ball RL, Kobayashi Y, Kimura T, Lee DP, Stefanick ML, Fearon WF, Yeung AC, Tremmel JA. Dose-Response Relationship Between Intracoronary Acetylcholine and Minimal Lumen Diameter in Coronary Endothelial Function Testing of Women and Men With Angina and No Obstructive Coronary Artery Disease. Circ Cardiovasc Interv. 2020 Apr;13(4):e008587.
    
    
33. Arashi H, Kobayashi Y, Price MJ, Nishi T, Chambers JW, Seto AH, Sarembock IJ, Raveendran G, Jeremias A, Fearon WF. Diagnostic Accuracy of Nonhyperemic Pressure Ratios Using a Pressure Sensing Microcatheter: The ACIST-FFR Study. JACC Cardiovasc Interv. 2020 May 25;13(10):1272-1275.
    
    
32. Tateishi K, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction. J Cardiol. 2020 May;75(5):473-477.
    
    
31. Saito Y, Kobayashi Y. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention. Cardiovasc Interv Ther. 2020;35:44-51.
    
    
30. Saito Y, Kobayashi Y. Update on Antithrombotic Therapy after Percutaneous Coronary Intervention. Intern Med. 2020;59:311-21.
    
    
29. Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Honye J. Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2020;35:1-12.
    
    
28. Saito Y, Kobayashi Y, Tanabe K, Ikari Y. Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective. Cardiovasc Interv Ther. 2020;35:19-29.
    
    
27. Mori N, Saito Y, Saito K, Matsuoka T, Tateishi K, Kadohira T, Kitahara H, Fujimoto Y, Kobayashi Y. Relation of Plasma Xanthine Oxidoreductase Activity to Coronary Lipid Core Plaques Assessed by Near-Infrared Spectroscopy Intravascular Ultrasound in Patients with Stable Coronary Artery Disease. Am J Cardiol. 2020;125:1006-12.
    
    
26. Saito Y, Kitahara H, Nishi T, Fujimoto Y, Kobayashi Y. Systemic Endothelial Dysfunction in Patients with Vasospastic and Microvascular Angina: Serum Uric Acid as a Marker of Reactive Hyperemia Index. Coron Artery Dis. 2020;31:565-6.
    
    
25. Saito Y, Kitahara H, Shoji T, Nakayama T, Fujimoto Y, Kobayashi Y. Decreased Double Product at Rest in Patients with Severe Vasospasm. Heart Lung Circ. 2020 Oct;29(10):1511-1516.
    
    
24. Saito Y, Shoji T, Tateishi K, Kitahara H, Fujimoto Y, Kobayashi Y. Mental Health Status in Patients Undergoing Intracoronary Acetylcholine Provocation Test. Adv Ther. 2020;37:3807-15.
    
    
23. Napp LC, Cammann VL, Jaguszewski M, Szawan KA, Wischnewsky M, Gili S, Knorr M, Heiner S, Citro R, Bossone E, D'Ascenzo F, Neuhaus M, Franke J, Sorici-Barb I, Noutsias M, Burgdorf C, Koenig W, Kherad B, Sarcon A, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Karakas M, Pott A, Meyer P, Arroja JD, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Hauck C, Paolini C, Bilato C, Imori Y, Kato K, Kobayashi Y, et al. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. Eur Heart J. 2020;41:3255-3268.
    
    
22. Cammann VL, Szawan KA, Stähli BE, Kato K, Budnik M, Wischnewsky M, et al. Age-Related Variations in Takotsubo Syndrome. J Am Coll Cardiol. 2020; 75: 1869-1877.
    
    
21. D'Ascenzo F, Gili S, Bertaina M, Iannaccone M, Cammann VL, Di Vece D, Kato K, et al. Impact of aspirin on takotsubo syndrome: a propensity score-based analysis of the InterTAK Registry. Eur J Heart Fail. 2020; 22: 330-337.
    
    
20. Tabata N, Al-Kassou B, Sugiura A, Shamekhi J, Sedaghat A, Treede H, Tsujita K, Werner N, Grube E, Nickenig G, Sinning JM. Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis. Clin Res Cardiol 2020;109(9):1165-1176.
    
    
19. Shamekhi J, Sugiura A, Tabata N, Al-Kassou B, Weber M, Sedaghat A, Werner N, Grube E, Nickenig G, Sinning JM. Impact of Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC cardiovascular interventions 2020;13(9):1135-1137.
    
    
18. Al-Kassou B, Kandt J, Lohde L, Shamekhi J, Sedaghat A, Tabata N, Weber M, Sugiura A, Fimmers R, Werner N, Grube E, Treede H, Nickenig G, Sinning JM. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR. JACC cardiovascular interventions 2020;13(12):1471-1480.
    
    
17. Kavsur K, Hupp H, Sugiura A, Öztürk C, Weber M, Nickenig G, Tiyerili V, Becher MU. Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation. Int J Cardiol. 2020;318:32-38.
    
    
16. Shamekhi J, Sugiura A, Tabata N, Al-Kassou B, Sedaghat A, Werner N, Grube E, Nickenig G, Sinning JM. Impact of tricuspid regurgitation in patients undergoing transcatheter aortic valve implantation. JACC cardiovascular interventions 2020;13(18):2137-2145.
    
    
15. Tabata N, Al-Kassou B, Sugiura A, Kandt J, Shamekhi J, Stundl A, Zimmer S, Treede H, Ishii M, Tsujita K, Werner N, Nickenig G, Sinning JM. Prognostic impact of cancer history in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 2020;109(10):1243-1250.
    
    
14. Sugiura A, Weber M, Efstratios CI, Treede H, Sinning JM, Nickenig G. Neochord system as an alternative option upon transmitral pressure gradient elevation in the MitraClip procedure. JACC Cardiovascular Interventions 2020;13(5):e39-e40.
    
    
13. Sugiura A, Oeztuerk C, Weber M, Sinning JM, Nickenig G. Staged grasping with the PASCAL device for mitral regurgitation with leaflet laceration. EuroIntervention. 2020;16(4):e303-e304.
    
    
12. Sugiura A, Weber M, Treede H, Nickenig G. Aortic valve deformation during transcatheter mitral valve implantation. JACC Cardiovascular Interventions 2020;13(13):1603-1604.
    
    
11. Sugiura A, Weber M, Tabata N, Goto T, Oeztuerk C, Hammerstingel C, Sinning JM, Werner N, Nickenig G. Prognostic impact of redo transcatheter mitral valve repair for recurrent mitral regurgitation. Am J Cardiol. 2020;130:123-129.
    
    
10. Sueda S, Shinohara T, Takahashi N, Shite J, Shoji T, Akao M, Kijima Y, Masuyama T, Miyaji T, Yamamoto K, Iwasaki Y, Yoshida R, Nakamura S, Ogino Y, Kimura K, Sasai M, Suzuki H, Wakatsuki T, Asajima H, Teragawa H, Ishikawa T, Kitamura K, Oda T, Nakayama T, Kobayashi Y, Sunada D, Yamaki M, Nishizaki F, Tomita Y, Usuda K, Fujinaga H, Kuramitsu S, Andou K, Kiyooka T, Kadota K, Ishii Y, Ohtani H, Maekawa Y, Taguchi E, Nakao K, Kobayashi N, Seino Y, Nakagawa H, Saito Y, Komuro I, Sasaki Y, Ikeda S, Yamaguchi O, Kakutani A, Imanaka T, Ishihara M, Ishii M, Kaikita K, Tsujita K. Questionnaire in patients with aborted sudden cardiac death due to coronary spasm in Japan. Heart Vessels. 2020;35(12):1640-1649.
    
    
9. Okada K, Honda Y, Kitahara H, Ikutomi M, Kameda R, Brooke Hollak M, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T; ABSORB Japan Investigators. Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial. Int J Cardiol Heart Vasc. 2020 Sep 4;31:100623.
   
   
8. Onuma Y, Honda Y, Asano T, Shiomi H, Kozuma K, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Hanaoka KI, Tanabe K, Okada K, Kitahara H, Ono M, Kusano H, Rapoza R, Simonton C, Popma JJ, Stone GW, Fitzgerald PJ, Serruys PW, Kimura T. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years. JACC Cardiovasc Interv. 2020 Jan 13;13(1):116-127.
   
   
7. Sugiura A, Kitahara H, Iwahana T, Suzuki N, Okada S, Miyauchi H, Kobayashi Y, Werner N. Association of heart failure duration with clinical prognosis in advanced heart failure. Clin Res Cardiol. 2020 Mar;109(3):350-357.
   
   
6. Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention. J Cardiol. 2020 Jun;75(6):654-658.
   
   
5. Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Honye J. Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2020;35(1):1-12.
   
   
4. Saito Y, Kobayashi Y. Update on Antithrombotic Therapy after Percutaneous Coronary Intervention. Intern Med. 2020;59(3):311-321
   
   
3. Saito Y, Kobayashi Y. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention. Cardiovasc Interv Ther. 2020;35(1):44-51.
   
   
2. Sugiura A, Kitahara H, Iwahana T, Eguchi N, Okada S, Miyauchi H, Kobayashi Y, Werner N. Association of Heart Failure Duration with Clinical Prognosis in Advanced Heart Failure. Clin Res Cardiol. 2020;109(3):350-357.
   
   
1. Sugiura A, Weber M, von Depka A, Tabata N, Shamekhi J, Al-Kassou B, Nickenig G, Werner N, Sinning JM, Sedaghat A. Outcomes of myocardial fibrosis in patients undergoing transcatheter aortic valve replacement. Eurointervention. 2020;15(16):1417-1423.

2019年

34. Okuya Y, Saito Y, Takahashi T, Kishi K, Hiasa Y. Novel Predictors of Late Lumen Enlargement in Distal Reference Segments after Successful Recanalization of Coronary Chronic Total Occlusion. Catheter Cardiovasc Interv. 2019;94:546-52.
    
    
33. Okuya Y, Saito Y, Takahashi T, Kishi K. Impact of Elevated Serum Uric Acid Level on Target Lesion Revascularization After Percutaneous Coronary Intervention for Chronic Total Occlusion. Am J Cardiol. 2019;124:1827-32.
    
    
32. Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita, K. Differential Predictive Factors For Cardiovascular Events in Patients With or Without Cancer History. Medicine (Baltimore). 2019;98:e17602.
    
    
31. Tabata N, Weber M, Sugiura A, Oeztuerk C, Ishii M, Tsujita K, Nickenig G, Sinning JM. Impact of the leaflet-to-annulus index on residual mitral regurgitation in patients undergoing edge-to-edge mitral repair. JACC cardiovascular interventions 2019;12(24):2462-2472.
    
    
30. Tabata N, Al-Kassou B, Sugiura A, Shamekhi J, Treede H, Tsujita K, Werner N, Grube E, Nickenig G, Sinning JM. Clinical Impact of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Implantation. J Am Coll Cardiol CardioOnc. 2019;1:159–169.
    
    
29. Tokimasa S, Kitahara H, Nakayama T, Fujimoto Y, Shiba T, Shikama N, Nameki M, Himi T, Fukushima KI, Kobayashi Y. Multicenter research of bleeding risk between prasugrel and clopidogrel in Japanese patients with coronary artery disease undergoing percutaneous coronary intervention. Heart Vessels. 2019 Oct;34(10):1581-1588.
    
    
28. Kitahara H, Mori N, Saito Y, Nakayama T, Fujimoto Y, Kobayashi Y. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention. Heart Vessels. 2019 Oct;34(10):1595-1599.
    
    
27. Tateishi K, Abe D, Suzuki K, Hamabe Y, Aonuma K, Sato A. Association Between Multivessel Coronary Artery Disease and Return of Spontaneous Circulation Interval in Acute Coronary Syndrome Patients with Out-of-Hospital Cardiac Arrest. Int Heart J. 2019;60:1043-1049.
    
    
26. Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita, K. Differential Predictive Factors For Cardiovascular Events in Patients With or Without Cancer History. Medicine (Baltimore). 2019;98(44):e17602.
    
    
25. Okuya Y, Saito Y, Takahashi T, Kishi K. Impact of Elevated Serum Uric Acid Level on Target Lesion Revascularization After Percutaneous Coronary Intervention for Chronic Total Occlusion. Am J Cardiol. 2019;124(12):1827-1832.
    
    
24. Saito Y, Kobayashi Y. Percutaneous coronary intervention strategies in patients with acute myocardial infarction and multivessel disease: Completeness, timing, lesion assessment, and patient status. J Cardiol. 2019;74:95-101.
    
    
23. Okuya Y, Saito Y, Takahashi T, Kishi K, Hiasa Y. Novel Predictors of Late Lumen Enlargement in Distal Reference Segments after Successful Recanalization of Coronary Chronic Total Occlusion. Catheter Cardiovasc Interv. 2019;94:546-52.
    
    
22. Saito Y, Kitahara H, Nishi T, Fujimoto Y, Kobayashi Y. Decreased Resting Coronary Flow and Impaired Endothelial Function in Patients with Vasospastic Angina. Coron Artery Dis. 2019;30:291-6.
    
    
21. Okuya Y, Saito Y, Sakai Y, Ishibashi I, Kobayashi Y. Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging. 2019;35:401-7.
    
    
20. Saito Y, Kobayashi Y. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention. J Cardiol. 2019;73:1-6.
    
    
19. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Endothelial Function and Long-Term Cardiovascular Events in Patients Undergoing Cardiovascular Surgery. Heart Vessels. 2019;34:318-23.
    
    
18. Saito Y, Kitahara H, Okuya Y, Nakayama T, Fujimoto Y, Kobayashi Y. Novel Predictor of Target Vessel Revascularization after Coronary Stent Implantation: Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound. Catheter Cardiovasc Interv. 2019;93:604-10.
    
    
17. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Relation of Elevated Serum Uric Acid Level to Endothelial dysfunction in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2019;26:362-7.
    
    
16. Kato K, Gili S, Fabbian F, Manfredini R. Co-morbidities in takotsubo syndrome. ESC CardioMed (3 edn). Part 3, section 30, chapter 30.9.
    
    
15. Kato K, Ishibashi I, Ghadri JR, Templin C. Biventricular takotsubo syndrome. Eur Heart J. 2019; 40: 2171.
    
    
14. Kato K, Di Vece D, Cammann VL, Micek J, Szawan KA, Bacchi B, Lüscher TF, Ruschitzka F, Ghadri JR, Templin C. Takotsubo Recurrence –Morphological Types and Triggers and Identification of Risk Factors. J Am Coll Cardiol. 2019; 73: 982-984.
    
    
13. Kato K, Templin C. Escape from the takotsubo octopus trap: liberation often temporary and readmission rates high. Eur Heart J Qual Care Clin Outcomes. 2019; 5: 88-89.
    
    
12. Nishi T, Funabashi N, Ozawa K, Nishi T, Kamata T, Fujimoto Y, Kobayashi Y. Regional layer-specific longitudinal peak systolic strain using exercise stress two-dimensional speckle-tracking echocardiography for the detection of functionally significant coronary artery disease. Heart Vessels. 2019;34(8):1394-1403.
    
    
11. Nishi T, Funabashi N, Fujimoto Y, Kobayashi Y. Simultaneous anterior and inferior myocardial infarction in a patient with a single coronary artery anomaly. Eur Heart J. 2019 May 3. pii: ehz262. doi: 10.1093/eurheartj/ehz262.
    
    
10. Sugiura A, Weber M, Sinning JM, Werner N, Nickenig G. Provisional closure of an iatrogenic atrial septal defect for shunt reversal after transcatheter treatment of tricuspid regurgitation. J Invasive Cardiol. 2019;31(10):E298-E299.
    
    
9. Kitahara H, Mori N, Saito Y, Nakayama T, Fujimoto Y, Kobayashi Y. Plaque Stabilization by Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor in a Patient With Familial Hypercholesterolemia Undergoing Percutaneous Coronary Intervention. Circ J. 2019;83(5):1084.
   
   
8. Oka N, Kadohira T, Fujii K, Kitahara H, Fujimoto Y, Kobayashi Y. Microbubble contrast enhancement of neointima after drug-eluting stent implantation: an optical coherence tomography study. Heart Vessels. 2019;34(3):393-400.
   
   
7. Saito Y, Kobayashi Y. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention. J Cardiol. 2019;73(1):1-6.
   
   
6. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Endothelial Function and Long-Term Cardiovascular Events in Patients Undergoing Cardiovascular Surgery. Heart Vessels. 2019;34(2):318-323.
   
   
5. Saito Y, Kitahara H, Okuya Y, Nakayama T, Fujimoto Y, Kobayashi Y. Novel Predictor of Target Vessel Revascularization after Coronary Stent Implantation: Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound. Catheter Cardiovasc Interv. 2019;93(4):604-610.
   
   
4. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Relation of Elevated Serum Uric Acid Level to Endothelial dysfunction in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2019;26(4):362-367.
   
   
3. Ohno Y, Kitahara H, Fujii K, Kohno Y, Ariyoshi N, Nishi T, Fujimoto Y, Kobayashi Y. High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis. J Cardiol. 2019;73(1):51-57.
   
   
2. Sugiura A, Weber M, Sinning JM, Werner N, Nickenig G. Staged Transcatheter Valve Repair via MitraClip XTR after Cardioband for Tricuspid Regurgitation. EHJ cardiovascular imaging 2019;20(1):118.
   
   
1. Sugiura A, Abe R, Nakayama T, et al. Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation after coronary revascularization for acute myocardial infarction complicated by cardiac arrest: A retrospective multicenter study. Shock. 2019;51(6):690-697.

2018年

21. Kato K, Cammann VL, Wischnewsky M, Ghadri JR, Templin C. Reply: Prevalence of Diabetes Mellitus in Patients with Takotsubo Syndrome, Precipitated by Nonphysical or No Triggers. J Am Coll Cardiol. 2018; 72: 2942-2944.
    
    
20. Ghadri JR*, Kato K* (*First two authors equally contributed to this work), Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimský P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Böhm M, Lüscher TF, Ruschitzka F, Templin C. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol. 2018; 72: 874-882.
    
    
19. Kato K, Sakai Y, Ishibashi I, Himi T, Fujimoto Y, Kobayashi Y. Predictors of in-hospital cardiac complications in patients with Takotsubo syndrome. Heart Vessels. 2018; 33: 1214-1219.
    
    
18. Kato K, Kobayashi Y. Author's reply. J Cardiol. 2018; 72: 177.
    
    
17. Nishi T, Kitahara H, Fujimoto Y, Nakayama T, Nagashima K, Hanaoka H, Kobayashi Y. Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study. Heart Vessels. 2018;33(12):1570-1575.
    
    
16. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Efficacy of radiation dose reduction due to real-time monitoring and visualization of peak skin dose during coronary angiography and percutaneous coronary intervention. Catheter Cardiovasc Interv. 2018;91:717-722.
    
    
15. Ichimoto E, Arnofsky A, Wilderman M, Goldweit R, De Gregorio J. Early Mortality and Safety After Transcatheter Aortic Valve Replacement Using the SAPIEN 3 in Nonagenarians. J Geriatr Cardiol. 2018;15:387-393.
    
    
14. Kitahara H, Mastuura K, Sugiura A, Yoshimura A, Muramatsu T, Tamura Y, Nakayama T, Fujimoto Y, Matsumiya G, Kobayashi Y. Recurrence of Left Ventricular Outflow Tract Obstruction Requiring Alcohol Septal Ablation after Transcatheter Aortic Valve Implantation. Case Rep Cardiol. 2018;2018:5026190.
    
    
13. Tateishi K, Saito Y, Kitahara H, Shoji T, Kadohira T, Nakayama T, Fujimoto Y, Kobayashi Y. Safety and usefulness of acetylcholine provocation test in patients with no culprit lesions on emergency coronary angiography. Int J Cardiol. 2018;269:27-30.
    
    
12. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Feasibility and Safety of Outpatient Cardiac Catheterization with Intracoronary Acetylcholine Provocation Test. Heart Vessels. 2018;33:846-52.
    
    
11. Nishi T, Kitahara H, Saito Y, Nishi T, Nakayama T, Fujimoto Y, Matsumiya G, Kobayashi Y. Invasive Assessment of Microvascular Function in Patients With Valvular Heart Disease. Coron Artery Dis. 2018;29:223-9.
    
    
10. Saito Y, Kobayashi Y. Intracoronary Acetylcholine Provocation Test via Coronary Bypass Graft. Circ J. 2018;82:1963-4.
    
    
9. Sugiura A, Kitahara H, Fujii K, Fujimoto Y, Kobayashi Y. Aortic Dissection Resulting in Simultaneous Bilateral Coronary Invasion via Different Mechanisms on Intravascular Ultrasonography. Circ J. 2018;82:2383-2384.
   
   
8. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Efficacy of radiation dose reduction due to real-time monitoring and visualization of peak skin dose during coronary angiography and percutaneous coronary intervention. Catheter Cardiovasc Interv. 2018 ;91(4):717-722.
   
   
7. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent. Int Heart J. 2018 ;59(1):14-20.
   
   
6. Delamination of novel ultrathin bioabsorbable abluminal polymer of platinum chromium everolimus-eluting stent. Fujimoto Y, Kobayashi Y, Kato K, Yamaguchi M. Cardiovasc Interv Ther. 2018 Jan;33(1):97-98.
   
   
5. Tateishi K, Abe D, Iwama T, Hamabe Y, Aonuma K, Sato A. Clinical value of ST-segment change after return of spontaneous cardiac arrest and emergent coronary angiography in patients with out-of-hospital cardiac arrest: Diagnostic and therapeutic importance of vasospastic angina. Eur Heart J Acute Cardiovasc Care. 2018;7(5):405-413.
   
   
4. Wakabayashi S, Kitahara H, Nishi T, Sugimoto K, Nakayama T, Fujimoto Y, Ariyoshi N, Kobayashi Y. Platelet inhibition after loading dose of prasugrel in patients with ST-elevation and non-ST-elevation acute coronary syndrome. Cardiovasc Interv Ther. 2018;33(3):239-246.
   
   
3. Kato K, Kobayashi Y. Is myocardial bridging transient in patients with takotsubo syndrome? - Reply. J Cardiol. 2018;71(1):110.
   
   
2. Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Efficacy of radiation dose reduction due to real-time monitoring and visualization of peak skin dose during coronary angiography and percutaneous coronary intervention. Catheter Cardiovasc Interv 2018;91(4):717-722.
   
   
1. Fujimoto Y, Kobayashi Y, Kato K, Yamaguchi M. Delamination of novel ultrathin bioabsorbable abluminal polymer of platinum chromium everolimus-eluting stent. Cardiovasc Interv Ther. 2018;33(1):97-98.

2017年

23. Okuya Y, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound, a Novel Predictor of Periprocedural Myocardial Injury After Coronary Stenting. Am J Cardiol. 2017;120:1084-9.
    
    
22. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Assessment of Endothelial Function for Prediction of Adverse Events After Cardiovascular Surgery. Circ J. 2017;82:118-22.
    
    
21. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation between severity of myocardial bridge and vasospasm. Int J Cardiol. 2017;248:34-8.
    
    
20. Kitahara H, Okada K, Kimura T, Yock PG, Lansky AJ, Popma JJ, Yeung AC, Fitzgerald PJ, Honda Y. Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions. Circ Cardiovasc Interv 2017;10:e004795.
    
    
19. Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter. Fujimoto Y, Tonoike N, Kobayashi Y. Cardiovasc Interv Ther. 2017 Apr ;32(2):142-145.
    
    
18. Okuya Y, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Intraluminal intensity of blood speckle on intravascular ultrasound, a novel predictor of periprocedural myocardial injury after coronary stenting. Am J Cardiol 2017;120:1084–1089.
    
    
17. Kato K, Lyon AR, Ghadri JR, Templin C. Takotsubo syndrome: aetiology, presentation and treatment. Heart. 2017 Sep;103(18):1461-1469.
    
    
16. Kato K, Kitahara H, Saito Y, Fujimoto Y, Sakai Y, Ishibashi I, Himi T, Kobayashi Y. Impact of myocardial bridging on in-hospital outcome in patients with takotsubo syndrome. J Cardiol. 2017;70(6):615-619.
    
    
15. Kato K, Daimon M, Ishibashi I, Kobayashi Y. Myocardial Edema in Takotsubo Syndrome - Serial Cardiovascular Magnetic Resonance Imaging of the Natural Course. Circ J. 2017;81(9):1368-1369.
    
    
14. Saito Y, Kitahara H, Matsumiya G, Kobayashi Y. Preoperative Assessment of Endothelial Function for Prediction of Adverse Events After Cardiovascular Surgery. Circ J. 2017;82(1):118-122.
    
    
13. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation between severity of myocardial bridge and vasospasm. Int J Cardiol. 2017; 248: 34-8.
    
    
12. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Night-time blood pressure variability negatively correlated with reactive hyperemia index. Int J Cardiol. 2017; 230: 332-4.
    
    
11. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery. Heart Vessels. 2017; 32: 685-9.Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Paroxysmal atrial fibrillation during intracoronary acetylcholine provocation test. Heart Vessels. 2017; 32: 902-8.
    
    
10. Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. Diagnostic Accuracy of Intraluminal Blood Speckle Intensity on Intravascular Ultrasound for Physiological Assessment of Coronary Artery Stenosis. Coron Artery Dis. 2017;28:145-50.
    
    
9. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Wakabayashi S, Hanaoka H, Kobayashi Y. Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients. J Cardiol. 2017 ;69(5):752-755.
   
   
8. Kitahara H, Waseda K, Sakamoto K, Yamada R, Huang CC, Nakatani D, Sakata K, Kawarada O, Yock PG, Matsuyama Y, Yokoi H, Nakamura M, Muramatsu T, Nanto S, Fitzgerald PJ, Honda Y. Impact of Attenuated-Signal Plaque Observed by Intravascular Ultrasound on Vessel Response After Drug-Eluting Stent Implantation. Atherosclerosis 2017;259:68-74.
   
   
7. Kadohira T, Mintz GS, Souza CF, Witzenbichler B, Metzger DC, Rinaldi MJ, Mazzaferri EL Jr, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Crowley A, Kirtane AJ, Stone GW, Maehara A. Impact of Chronic Statin Therapy on Clinical Presentation and Underlying Lesion Morphology in Patients Undergoing Percutaneous Intervention: An ADAPT-DES IVUS Substudy. Coron Artery Dis. 2017; 28(3):218-224.
   
   
6. Kadohira T, Kobayashi Y. Intravascular ultrasound-guided drug-eluting stent implantation.Cardiovasc Interv Ther. 2017;32(1):1-11.
   
   
5. Fujimoto Y, Tonoike N, Kobayashi Y.Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter.Cardiovasc Interv Ther. 2017 ;32(2):142-145.
   
   
4. Kato K, Kobayashi Y. Validation of proposed risk stratification system for in-hospital cardiac complications in patients with takotsubo syndrome. ESC Heart Fail. 2017;4(1):78.
   
   
3. Takahara M, Kitahara H, Nishi T, Miura K, Miyayama T, Sugimoto K, Nakayama T, Fujimoto Y, Kobayashi Y. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study. Int J Cardiovasc Imaging. 2017;33(1):25-30.
   
   
3. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Wakabayashi S, Hanaoka H, Kobayashi Y. Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients. J Cardiol. 2017;69(5):752-755.
   
   
2. Nishi T, Kitahara H, Fujimoto Y, Nakayama T, Sugimoto K, Takahara M, Kobayashi Y. Comparison of 3-dimensional and 2-dimensional quantitative coronary angiography and intravascular ultrasound for functional assessment of coronary lesions. J Cardiol. 2017;69(1):280-286.
   
   
1. Fujimoto Y, Tonoike N, Kobayashi Y. Successful delivery of polytetrafluoroethylene-covered stent using rapid exchange guide extension catheter. Cardiovasc Interv Ther. 2017;32(2):142-145.

2016年

19. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Predictive value of coronary artery dilation response to nitrate for a positive intracoronary acetylcholine provocation test. Coron Artery Dis. 2016;27:551-5.
    
    
18. Ohno Y, Okada S, Kitahara H, Nishi T, Nakayama T, Fujimoto Y, Kobayashi Y. Repetitive stent thrombosis in a patient who had resistance to both clopidogrel and prasugrel. Journal of Cardiology Cases. 2016;13(5):139-142.
    
    
17. Sugiura A, Nakayama T, Takahara M, Sugimoto K, Hattori N, Abe R, Fujimoto Y, Oda S, Kobayashi Y. Combined use of extracorporeal membrane oxygenation and hemodialysis in the case of contrast-induced biphasic anaphylactic shock. Am J Emerg Med. 2016;34(9):1919.e1-2.
    
    
16. Saito Y, Okada S, Funabashi N, Kobayashi Y. ANCA-negative eosinophilic granulomatosis with polyangitis (EGPA) manifesting as a large intracardiac thrombus and glomerulonephritis with angionecrosis. BMJ Case Rep. 2016. pii: bcr2016216520.
    
    
15. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery. Circ J. 2016;80:1820-3.
    
    
14. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Predictive value of coronary artery dilation response to nitrate for a positive intracoronary acetylcholine provocation test. Coron Artery Dis. 2016;27:551-5.
    
    
13. Saito Y, Takaoka H, Funabashi N, Ozawa K, Tamura Y, Saito M, Matsumiya G, Kobayashi Y. A case of very severe aortic stenosis due to unicuspid aortic valve mimicking bicuspid aortic valve with calcification on cardiac computed tomography. Int J Cardiol. 2016;215:516-8.
    
    
12. Kato K, Kobayashi Y. Documentation of Focal Takotsubo Syndrome and Its Diagnostic Implication -Reply-. Circ J. 2016;80:2059.
    
    
11. Kato K, Kitahara H, Fujimoto Y, Sakai Y, Ishibashi I, Himi T, Kobayashi Y. Prevalence and Clinical Features of Focal Takotsubo Cardiomyopathy. Circ J. 2016;80:1824-1829.
    
    
10. Kato K, Daimon M, Sugiura A, Kobayashi Y. Transient Semi-Circumferential Mid-Ventricular Ballooning: An Atypical Variant of Takotsubo Cardiomyopathy. J Cardiol Cases. 2016;14:21-23.
    
    
9. Kato K, Kitahara H, Kobayashi Y. Recurrence of Takotsubo Cardiomyopathy (Review). Int Cardiovasc Forum J. 2016;5:50-52.
   
   
8. Nishi T, Takaoka H, Funabashi N, Nishimura M, Ohara O, Makiyama T, Ueda M, Kajiyama T, Kobayashi Y. Familial lamin A/C mutation cardiomyopathy with arrhythmia substrate detected by cardiac magnetic resonance imaging and electroanatomical mapping. Int J Cardiol. 2016 Apr 15;209:248-52.
   
   
7. Nishi T, Kitahara H, Iwata Y, Fujimoto Y, Nakayama T, Takahara M, Sugimoto K, Kobayashi Y. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve. J Cardiol. 2016; 68(6):512-516.
   
   
6. Nishi T, Hasegawa A, Miyahara H, Nameki M, Kobayashi Y. In-stent accordion phenomenon. Int J Cardiol. 2016;220:129-30.
   
   
5. Nishi T, Funabashi N, Ozawa K, Takahara M, Fujimoto Y, Kamata T, Kobayashi Y. Resting multilayer 2D speckle-tracking transthoracic echocardiography for the detection of clinically stable myocardial ischemic segments confirmed by invasive fractional flow reserve. Part 1: Vessel-by-vessel analysis. Int J Cardiol. 2016 Sep 1;218:324-32.
   
   
4. Kitahara H, Waseda K, Yamada R, Otagiri K, Tanaka S, Kobayashi Y, Okada K, Kume T, Nakagawa K, Teramoto T, Ikeno F, Yock PG, Fitzgerald PJ, Honda Y. Acute stent recoil and optimal balloon inflation strategy: an experimental study using real-time optical coherence tomography. EuroIntervention 2016;12:e190-198.
   
   
3. Kitahara H, Okada K, Tanaka S, Yang HM, Miki K, Kobayashi Y, Kimura T, Luikart H, Yock PG, Yeung AC, Fitzgerald PJ, Khush KK, Fearon WF, Honda Y. Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients. J Heart Lung Transplant 2016;35:752-759.
   
   
2. Kitahara H, Waseda K, Yamada R, Sakamoto K, Yock PG, Fitzgerald PJ, Honda Y. Relative dose and vascular response after drug-eluting stent implantation: A dosimetric 3D-intravascular ultrasound study. Int J Cardiol 2016;204:211-217.
   
   
1. Aoki Y, Ishikawa K, Miura K, Sugimoto K, Nakayama T, Fujimoto Y, Kobayashi Y. Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation. J Cardiol. 2016;67:236-40.

2015年

10. Saito Y, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid. Am J Cardiol. 2015;116:1346-50.
    
    
9. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Takahara M, Wakabayashi S, Koshizaka M, Hanaoka H, Kobayashi Y. Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in Japanese patients with stable coronary artery disease. Circ J. 2015;79(11):2439-44.
   
   
8. Kitahara H, Honda Y, Fitzgerald PJ. Intravascular Ultrasound. In Textbook of PanVascular Medicine, 2nd edition. 2015:1379-1418.
   
   
7. Saito Y, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y. Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid. Am J Cardiol. 2015;116:1346-50.
   
   
6. Saito Y, Takaoka H, Funabashi N, Hasegawa H, Ozawa K, Omoto A, Usui H, Shozu M, Kobayashi Y. Early pregnancy-associated cardiomyopathy complicated with a complete hydatidiform mole coexistent with a live fetus and exacerbated by induced abortion. Int J Cardiol. 2015;198:170-3.
   
   
5. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Transient focal left ventricular ballooning: a new variant of Takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2015;16(12):1406.
   
   
4. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Reply: Takotsubo syndrome-induced acute myocardial infaction. Int J Cardiovasc Imaging. 2015;31:1019.
   
   
3. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Mid-ventricular takotsubo cardiomyopathy preceding acute myocardial infaction. Int J Cardiovasc Imaging. 2015;31:821-2.
   
   
2. Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Takahara M, Wakabayashi S, Koshizaka M, Hanaoka H, Kobayashi Y. Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Japanese Patients With Stable Coronary Artery Disease. Circ J. 2015 Oct 23;79(11):2439-44.
   
   
1. Miura K, Nakaya H, Kobayashi Y. Experimental assessment of effects of antiproliferative drugs of drug-eluting stents on endothelial cells. Cardiovasc Revasc Med. 2015 ;16 (6):344-7.

2014年

4. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Recurrent mid-ventricular takotsubo cardiomyopathy. Int J Cardiovasc Imaging. 2014;30:1417-8.
   
   
3. Kato K, Sakai Y, Ishibashi I, Kobayashi Y. Recurrent mid-ventricular takotsubo cardiomyopathy. International Journal of Cardiovascular Imaging.Int J Cardiovasc Imaging. 2014; 30:1417-8.
   
   
2. Ohkubo K, Fujimoto Y, Iwata Y, Kitahara H, Kadohira T, Sugimoto K, Morino T, Kobayashi Y.Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart Vessels. 2014;29:1-6.
   
   
1. Fujimoto Y, Iwata Y, Yamamoto M, Kobayashi Y.Usefulness of Corsair microcatheter to cross stent struts in bifurcation lesions. Cardiovasc Interv Ther. 2014; 29:47-51

2013年

2. Iwata Y, Fujimoto Y, Morino T, Sugimoto K, Ohkubo K, Kadohira T, Fukushima K, Kitahara H, Komuro I, Kobayashi Y.Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial. Am Heart J. 2013;165:408-14.
   
   
1. Kitahara H, Fujimoto Y, Ishikawa K, Aoki Y, Iwata Y, Kadohira T, Morino T, Ohkubo K, Sugimoto K, Kobayashi Y.Recovery of endothelial function after sirolimus-eluting stent implantation: a pilot study. Angiology 2013;64:211-5.

2012年

1. Fujimoto Y, Matsudo Y, Kobayashi Y. Successful delivery of polytetrafluoroethylene-covered stent through 5 French guiding catheter. J Invasive Cardiol. 2012; 24:E199-201.

2011年

2. Kitahara H, Kobayashi Y, Iwata Y, Fujimoto Y, Komuro I.Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation. Am J Cardiol 2011;108:214-9.
   
   
1. Kadohira T, Kobayashi Y, Iwata Y, Kitahara H, Komuro I.Coronary artery endothelial dysfunction associated with sleep apnea. Angiology 2011;62:397-400.

2010年

6. Morino T, Kobayashi Y, Fujimoto Y, Himi T, Komuro I. Bare metal stent restenosis is benign clinical entity in Japanese patients. Int Heart J 2010;51:227-30.
   
   
5. Ichimoto E, Kobayashi Y, Iijima Y, Kuroda N, Kohno Y, Komuro I. Long-term clinical outcomes after sirolimus-eluting stent implantation in dialysis patients. Int Heart J 2010;51:92-7.
   
   
4. Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Nomura F, Komuro I. Effect of 450-mg loading dose of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement. Heart Vessels 2010;25:182-6.
   
   
3. Nakayama T, Komiyama N, Yokoyama M, Namikawa S, Kuroda N, Kobayashi Y, Komuro I. Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound. Int J Cardiol 2010;138:157-65.
   
   
2. Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Kuwabara Y, Nomura F, Komuro I. Antiplatelet effect of 50-mg maintenance dose of clopidogrel compared to 200-mg ticlopidine: a preliminary study. Heart Vessels 2010;25:41-4.
   
   
1. Ishio N, Kobayashi Y, Iwata Y, Kitahara H, Fukushima K, Asano T, Nakayama T, Kuroda N, Komuro I. Ubiquitous atherosclerosis in coronary arteries without angiographically significant stenosis.Heart Vessels 2010;25:35-40.

2009年

7. Kadohira T, Kobayashi Y, Niitsuma Y, Imamaki M, Komuro I. Global ST-segment elevation associated with impending cardiac rupture during diagnostic cardiac catheterization. Int Heart J 2009;50:539-42.
   
   
6. Nakayama T, Kobayashi Y, Takano H, Kuroda N, Hiroshima K, Komuro I. Silent very late thrombotic occlusion of sirolimus-eluting stent confirmed by directional coronary atherectomy. Circ J 2009;73:1762-4.
   
   
5. Sugimoto K, Kobayashi Y, Miyahara H, Kuroda N, Funabashi N, Komuro I. Early stent thrombosis due to stent dislodgement in coronary artery aneurysm. Circ J 2009;73:1759-61.
   
   
5. Sugimoto K, Kobayashi Y, Kuroda N, Komuro I. Cost analysis of sirolimus-eluting stents in Japanese health insurance system. Int Heart J 2009;50:723-30.
   
   
4. Ichimoto E, Jo K, Kobayashi Y, Inoue T, Nakamura Y, Kuroda N, Miyazaki A, Komuro I. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction. Circ J 2009;73:1669-73.
   
   
3. Kitahara H, Kobayashi Y, Takebayashi H, Fujimoto Y, Nakamura Y, Kuroda N, Himi T, Miyazaki A, Haruta S, Komuro I, M. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis. Circ J 2009;73:867-71.
   
   
2. Asano T, Kobayashi Y, Fukushima K, Iwata Y, Kitahara H, Ishio N, Nakayama T, Kuroda N, Komuro I. Effect of balloon inflation time on expansion of sirolimus-eluting stent. Heart Vessels 2009;24:335-9.
   
   
1. Kitahara H, Kobayashi Y, Takebayashi H, Nakamura Y, Kuroda N, Miyazaki A, Haruta S, Komuro I. Angiographic patterns of restenosis after sirolimus-eluitng stent implantation. Circ J 2009;73:508-11.

2008年

8. Kitahara H, Kobayashi Y, Yamaguchi M, Ohkubo K, Nakayama T, Kuroda N, Komuro I. Damage to polymer of paclitaxel-eluting stent. Circ J 2008;72:1907-8.
   
   
7. Kadohira T, Kobayashi Y, Asano T, Uehara M, Funabashi N, Nakayama T, Kuroda N, Komuro I. Fatal very late stent thrombosis in a young diabetic patient with severely diffuse coronary atherosclerosis. Int Heart J 2008;49:507-13.
   
   
6. Ohkubo K, Kobayashi Y, Issei Komuro. Do Not Forget Vasospastic Angina in Patients With Chest Pain at Rest and No Significant Coronary Stenosis With Multidetector Computed Tomography. Am J Cardiol 2008;101:1519.
   
   
5. Kitahara H, Kobayashi Y, Yamaguchi M, Fujimoto Y, Nameki M, Nakayama T, Kuroda N, Komuro I. Damage to Polymer of Undelivered Sirolimus-eluting Stents. J Invas Cardiol 2008;20:130-3
   
   
4. Asano T, Kobayashi Y, Fukushima K, Iwata Y, Kitahara H, Ishio N, Kuroda N, Komuro I. Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting. Circ J 2008;72:1707-8.
   
   
3. Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Nakayama T, Kuroda N, Ooyama M, Nomura F, Komuro I. Effect of 150-mg vs 300-mg Loading Doses of Clopidogrel on Platelet Function in Japanese Patients Undergoing Coronary Stent Placement. Circ J 2008;72:1282-4.
   
   
2. Iwata Y, Kobayashi Y, Fukushima K, Kitahara H, Asano T, Ishio N, Nakayama T, Kuroda N, Komuro I. Incidence of Premature Discontinuation of Antiplatelet Therapy After Sirolimus-eluting Stent Implantation. Circ J 2008;72:340-1.
   
   
1. Kitahara H, Kobayashi Y, Fujimoto Y, Nakamura Y, Nakayama T, Kuroda N, Himi T, Miyazaki A, Komuro I. Late Stent Thrombosis in Patients Receiving Ticlopidine and Aspirin After Sirolimus-eluting Stent Implantation. Circ J 2008;72:168-9.

2007年

3. Asano T, Kobayashi Y, Ohno M, Nakayama T, Kuroda N, Komuro I. Multivessel Coronary Artery Spasm Refractory to Intensive Medical Treatment. Angiology 2007;58:636-9
   
   
2. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, Kuroda N, De Gregorio J, Kouno Y, Suzuki M, Haruta S, Komuro I. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007;71:1525-9.
   
   
1. Fukushima K, Kobayashi Y, Okuno T, Nakamura Y, Sakakibara M, Nakayama T, Kuroda N, Miyazaki A, Shimizu Y, Komuro I. Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation. Circ J 2007;71:617-9.

2006年

3. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I. Damage to polymer of a sirolimus-eluting stent. Circulation 2006;114:e586-7.
   
   
2. Yoshida T, Kobayashi Y, Nakayama T, Kuroda N, Komiyama N, Komuro I. Stent deformity caused by coronary artery spasm. Circ J 2006;70:800-1.
   
   
1. Asano T, Kobayashi Y, Mintz GS, Ishio N, Fujimaki S, Ogawa Y, Nakayama T, Kuroda N, Komuro I. Effect of plaque volume on subsequent vessel remodeling at edges of sirolimus-eluting stents. Am J Cardiol 2006;98:1041-4.

2003年

2. Kuroda N, Kobayashi Y, Mintz GS, Komuro I. Multiple Ruptured Plaques: Serial Intravascular Ultrasound Examinations. Circulation 2003;108:e131-132.
   
   
1. Kuroda K, Kobayashi Y, Desai K, Costantini C, Kobayashi M, Komuro I. Impact of change in prices of percutaneous coronary intervention devices on medical expenses. Circ J 2003;67:576-8.

2002年

2. Kuriyama N, Kobayashi Y, Kuroda N, Desai K, Yamamoto Y, Komiyama N, Komuro I, Fitzgerald PJ. Effect of coronary stent overexpansion on lumen size and intimal hyperplasia at follow-up. Am J Cardiol 2002;89:1297-1299
   
   
1. Kuroda N, Kobayashi Y, Nameki M, Kuriyama N, Kinoshita T, Okuno T, Yamamoto Y, Komiyama N, Masuda Y. Intimal hyperplasia regression from 6 to 12 months after stenting. Am J Cardiol 2002;89:869-872

2000年

1. Kuroda N, Kobayashi Y, Yamamoto Y, Komiyama N, Masuda Y. Limited balloon expansion through the struts of the Palmaz-Schatz and NIR stents compared with the Multi-Link stent. Jpn Circ J. 2000;64:883-885.

• 原著論文・症例報告
• 国際学会発表